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ABSTRACT 
 The 7-deazaguanosine nucleosides queuosine (Q) and archaeosine (G+) are two 
of the most structurally complex modified nucleosides found in tRNA.  Q is found 
exclusively in the wobble position of tRNAGUN coding for the amino acids asparagine, 
aspartate, histidine and tyrosine in eukarya and bacteria, while G+ occurs in nearly all 
archaeal tRNA at position 15.   
 In archaea preQ0 is inserted into tRNA by the enzyme tRNA-guanine 
transglycosylase (TGT), which catalyzes the exchange of guanine with preQ0 to 
produce preQ0-tRNA.  The first objective of this study was to identify and characterize 
the enzyme(s) catalyzing the conversion of preQ0-tRNA to G+-tRNA.  Comparative 
genomics identified a protein family possibly involved in the final steps of archaeosine 
biosynthesis, which was annotated as TgtA2.  Structure based alignments comparing 
TGT and TgtA2 revealed that TgtA2 lacked key TGT catalytic residues and contained 
an additional module.  The gene corresponding to tgtA2 from Methanocaldococcus 
jannaschii (mj1022) was cloned, expressed and the purified recombinant enzyme 
characterized.  Recombinant MjTgtA2 was shown to convert preQ0-tRNA to G+-tRNA 
using glutamine, asparagine or NH4+ as nitrogen donors in an ATP-independent 
reaction.  This is the only example of the conversion of a nitrile to a formamidine 
known in biology.   
 QueF catalyzes the reduction of preQ0 to 7-aminomethyl-7-deazaguanine 
(preQ1) in the queuosine biosynthetic pathway.  The second aim of this study was the 
transient state kinetic analysis of substrate binding and catalysis by the enzyme QueF, 
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as well as investigation of the effects of ligands on its quaternary structure.  Gel 
filtration and sedimentation equilibrium analyses indicated that QueF exists as a 
hybrid population in a rapid equilibrium between decamer and pentamer states.  
Addition of preQ0 to QueF resulted in shifting the equilibrium towards the decamer 
state, as did the addition of divalent metals.  Potassium chloride at high concentrations 
was found to disrupt the quaternary structure of QueF.  Intrinsic tryptophan and 
NADPH fluorescence was used to determine the substrate binding to QueF by 
stopped-flow kinetic studies.  Studies on the binding of preQ0 to QueF in conjuction 
with binding NADPH to the QueF mutant E78A-thioimide intermediate suggested a 
two-step mechanism consisting of a fast bimolecular process and a subsequent slower 
unimolecular process, while the binding of preQ0 to the C55A mutant was 
monophasic, consisting of only the fast bimolecular process.  Thioimide formation 
was monitored by UV-Vis; under single turnover conditions the data fit well to single 
exponential rise.  However, at high preQ0 concentrations two phases could be 
observed.  The reduction of the thioimide was determined under single turnover 
conditions by both UV-Vis and fluorescence, and comparable rates were obtained 
from both techniques.  These results indicate that the binding of preQ0 and NADPH to 
QueF, as well as thioimide formation, are very rapid; and that reduction of the 
thioimide is most likely the rate limiting step.  Analysis of component rates suggests 
structural changes occur between these steps, further limiting the overall rate.  
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1. INTRODUCTION 
1.1 Transfer ribonucleic acids 
 Structure and function 
Transfer ribonucleic acid (tRNA) is the information adapter molecule interfacing the 
amino-acid sequence of a protein and the genetic information in deoxyribonucleic acid 
(DNA).  The function of tRNA is essential to the process of translation, engaging in 
highly specific interactions with both nucleic acids and proteins.  Most tRNAs from all 
organisms have a similar cloverleaf-fold secondary structure.  Typically, there are four 
arms and three loops: the acceptor, D (dihydrouridine), TΨC (T-pseudouridine-C) and 
anticodon arms, D, TΨC and anticodon loops (some tRNA molecules feature a fourth or 
variable loop).  The tertiary L-shape of tRNA is the result of the stacking of the acceptor 
arm onto the TΨC arm and of the D arm onto the anticodon arm yielding the acceptor 
stem and anticodon stem respectively (1).  Most tRNAs have between 75-95 nucleotides. 
 
In addition to the role of tRNA in protein synthesis, tRNA is also involved in a variety of 
other functions, including the activation of amino acids, initiation and regulation of 
protein synthesis, RNA metabolism, nuclease degradation, reverse transcriptase primer, 
cell wall biosynthesis, membrane components and protein modification (2). 
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Modification of nucleoside bases 
A characteristic structural feature of RNA is the presence of post-transcriptional 
modifications, with naturally occurring RNAs containing numerous chemically altered 
nucleosides.  They are formed by enzymatic modification of the primary transcripts 
during the complex RNA maturation process.  To date, over 100 structurally 
distinguishable modified nucleosides originating from different types of RNAs have been 
reported and collected in the RNA Modification Database (3, 4).  The extent of total 
nucleoside modification in tRNA molecules from plant and mammals is high (up to 
25%), whereas that in homologous tRNAs from bacteria is lower (2-15%) and the 
organelles have the lowest level of modification (1-6%) (5). 
 
The modifications of the four canonical nucleosides adenosine, guanosine, uridine and 
cytosine vary from simple structural changes of the base or ribosyl moieties to hyper-
modifications (1).  Simple modifications typically require a single enzyme and involve a 
small structural change such as methylation, isomerization or reduction of a base (1), 
whereas hyper-modification of nucleosides typically involves multiple enzymatic steps 
and results in substantial structural changes (1).  Very few enzymes are needed for the 
transcription of tRNA, whereas a vast number participate in its post-transcriptional 
modification.  An estimated 1% of bacterial genomes are dedicated to encoding genes 
necessary for tRNA nucleoside modifications (6), indicating the importance of such 
modifications to cell function.  
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Function of modified nucleosides 
The structural complexities of many modified nucleosides, their locations in specific sites 
in the tRNA molecule and their ubiquitous presence in a wide variety of organisms imply 
a critical role in tRNA function.  By the end of 2008, 107 structurally distinct modified 
nucleosides had been identified from different RNAs from various Eukarya, Bacteria, or 
Archaea.  Some modifications are found in all the three domains while others are only 
found in either one or two domains (5). 
 
Modifications in the tRNA anticodon region are particularly prevalent and directly affect 
tRNA function by modulating codon-anticodon interactions; 30-40% of all codon 
recognition is accomplished through tRNA wobble recognition of more than one codon 
(7).  Many post-transcriptional modifications have been found to occur at the tRNA’s 
wobble position 34 as well as position 37 (3’-adjacent to the anticodon); these are the two 
most modified positions in tRNA with the greatest variety of modification chemistries 
found among all tRNAs (7).  Many modifications located outside of the anticodon region 
function in general to stabilize the L-shaped tertiary structure of tRNA (8). 
 
Some base modifications found at the wobble position appear to have evolved to counter 
wobble base pairing while others evolved to facilitate it.  Modifications in the anticodon 
stem loop also aid in reading frame maintenance, promote translocation and cognate 
codon binding, as well as changing the codon read (9) as in lysidine (k2C) (7).  Lysidine 
is a lysine (Lys)-containing cytidine derivative that occurs at the wobble position of 
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tRNAIle that bear the CAU anticodon in their tRNA sequence and are specific for the 
AUA codon (7).  The CAU anticodon also occurs in tRNAMet responsible for AUG 
decoding.  The lysidine modification converts the codon specificity of tRNA with the 
CAU anticodon from AUG to AUA and the amino acid specificity from methionine 
(Met) to isoleucine (Ile), thus preventing the misreading of AUA as Met (10).  
 
Position 37 of the tRNA usually contains a modified purine nucleoside.  Transfer RNAs 
recognizing codons beginning with A usually have N6-threonylcarbamoyl-adenosine 
(t6A) at this position (1).  These modifications play a critical role in the stabilization of 
codon-anticodon pairing through base-stacking interactions and function to maintain the 
reading frame (1).  Another modification that occurs at this position is N1-methyl-
guanosine (m1G), which is conserved among the three domains of life (11).  It has been 
found to play various roles in different tRNAs.  In bacterial tRNAPro, the methyl group at 
the N1 position of G37 prevents incorrect base pairing with messenger RNA (12), it also 
contributes to efficient and accurate aminoacylation.  In archaeal tRNACysGCA m1G37 
enhances the aminoacylation rates of phosphoseryl-tRNA synthetase (13, 14) and 
cysteinyl-tRNA synthetase (13).  Other functions of specific tRNA modifications include 
HIV replication (m1A58) (15), cell cycle control (ms2i6A37) (16), and vitamin B6 
metabolism (Ψ38-40) (17).  
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1.2 Deazaguanosine derivatives: archaeosine and queuosine 
Archaeosine and queuosine are two of the most structurally complex hypermodified 
nucleosides identified in tRNA (Figure 1).  Both modified nucleosides share the unusual 
7-deazaguanosine core in which the N-7 atom of the base is replaced by a carbon.  
Queuosine is characterized by a cyclopentenediol ring appended to 7-aminomethyl-7-
deazaguanosine (18, 19), whereas in archaeosine there is a formamidino side chain at 
position 7 (20). 
 
Archaeosine 
Archaeosine (G+) occurs specifically at position 15 in the dihydrouridine loop of archael 
tRNA, a site not modified in known bacterial and eukaryotic tRNA sequences.  
Archaeosine was first discovered during the sequencing of tRNAMet from Thermoplasma 
acidophilium (21).  Its structure was shown to be neither purine nor pyrimidine but 7-
formamidino-7-deazaguanosine (20). 
 
Tertiary base pairs are important to the structure of canonical tRNAs.  Pairing of base 15 
to 48 is crucial as it brings together the D and V loops, and is referred to as the Levitt 
base pair (Figure 2).  Nucleotides at positions 15 and 48 do not form the canonical 
Watson-Crick base pairing, but form a reverse Watson-Crick (RWC) pairing (22).  Proper 
folding interactions in tRNAPhe from yeast has been shown to require G15-C48 base pair 
for the correct interaction of the T and D arms (23).  Magnesium binding and archaeosine 
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modification have been suggested to stabilize the Levitt base pair in tRNAs by inducing 
electron redistribution, which results in stabilization of the RWC geometry (24) (Figure 
3).  The positively charged formamidine group of archaeosine at the interface of the D-
loop/T-stem in the tertiary structure of the tRNA has also been suggested to be important 
in structural stabilization of the tRNA through electrostatic interactions with the anionic 
phosphates (20). 
 
Queuosine 
Queuosine (Q) and its derivatives are found at position 34 in tRNA with the GUN 
anticodon (tRNAAsp,Asn,His,Tyr) (25-28) exclusively in bacteria and eukaryotes, with the 
exception of Saccharomyces cerevisiae, Thermus thermophilus, mycobacterium and 
mycoplasma.  Queuosine can be further modified by the addition of a mannosyl group to 
Q-tRNAAsp or galactosyl group to Q-tRNATyr in mammalian tRNA (29), or glutamate to 
tRNAAsp in bacteria (30).  Queuosine has been implicated in a number of physiological 
phenomena including eukaryotic cell proliferation and differentiation (31), tyrosine 
biosynthesis in mammals (32), translational frameshifts essential to retroviral protein 
biosynthesis (33, 34) and bacterial virulence (35).  In eukaryotes queuosine has been 
further shown to be important in neoplasm staging (36).  Most of the evidence to date 
support the hypothesis that queuosine plays a role in modulating translational fidelity 
(37).  From experimental data (38) and computational modeling based on the crystal 
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structure of tRNAAsp it appears that queuosine is structurally restrictive for anticodon 
loop flexibility (36), which could function in eliminating codon bias. 
 
1.3 Queuosine and archaeosine biosynthesis  
The first step of Q and G+ biosynthesis in bacteria and archaea, respectively, follows the 
pathway of pteridines and folic acid biosynthesis (39) as well as that of the 7-deaza-
adenine antitumor antibiotics such as toyocamycin (40), with GTP cyclohydrolase I 
(GCYH-I) (41, 42) which catalyzes the conversion of GTP to 7,8-dihydroneopterin 
triphosphate (H2NTP). 
 
Comparative genomics resulted in identification of four genes (queC, queD, queE, and 
queF), which are involved in the queuosine biosynthetic pathway of Bacillus subtilis (B. 
subtilis) in a previously undefined operon (43).  E. coli QueD was recently shown to 
catalyze the conversion of 7,8-dihydroneopterin triphosphate to 6-carboxy-5,6,7,8-tetra-
hydropterin (CPH4) (44), which is then converted to the novel intermediate 7-carboxy-7-
deazaguanine (CDG) (45) by QueE, a member of the radical SAM enzyme superfamily.  
Radical SAM proteins catalyze diverse reactions, including unusual methylations, 
isomerization, sulfur insertion, ring formation, anaerobic oxidation and protein radical 
formation (46).  The carboxylate moiety on CDG is converted subsequently to a nitrile to 
yield preQ0 by QueC an ATP-dependent reaction, in which ammonia serves as the 
nitrogen source (45).  The preQ0 biosynthetic pathway is shown in Figure 4.   
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The pathways for Q and G+ diverge after the formation of preQ0.  In bacteria NADPH 
dependent 7-cyano-7-deazaguanine oxidoreductase (QueF) catalyzes the NADPH-
dependent conversion of the nitrile moiety of preQ0 to the primary amine group in 7-
aminomethyl-7-deazaguanine (preQ1) (47).  The bacterial tRNA-guanine transglycosy-
lase (TGT) then introduces preQ1 into an appropriate tRNA with the concomitant release 
of the genetically encoded guanine at position 34 (48).  TGT catalyzes the base-exchange 
reaction by cleaving the N-glycosidic bond, without breaking the phosphodiester 
backbone (49).  The penultimate step is catalyzed by QueA which results in the 
introduction of an epoxyclopentanediol ring to the primary amine of preQ1 forming the 
intermediate epoxy-queuine (oQ) (50).  The final conversion to form the 
cyclopentenediol of queuosine is catalyzed by an uncharacterized enzyme that may be 
B12-dependent (51).  Eubacteria are unique in their ability to synthesize queuosine de 
novo, whereas eukaryotes utilize a salvage system or acquire queuine from their diet and 
from intestinal flora (28, 52, 53), and insert this directly into tRNA by the eukaryotic 
TGT (54).   
 
In archaea, preQ0 is directly incorporated into the tRNA by an archaeal TGT, which 
exchanges preQ0 for the guanine in position 15 of tRNA resulting in the formation of 
preQ0-tRNA.  In vitro guanine was found to be a substrate to archaeal TGT, but not 
preQ1, archaeosine, and queuine (55).  The biosynthetic pathways of archaeosine and 
queuosine are shown in Figure 5.  The enzyme responsible for the conversion of preQ0-
tRNA to G+-tRNA was unknown until the work reported in this thesis.  
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1.4 NADPH 7-cyano-7-deazaguanine oxidoreductase (QueF) 
QueF is an oxidoreductase that utilizes two equivalents of NADPH in a four electron 
reduction of the nitrile group of preQ0 to the primary amine of preQ1 (47).  The reaction 
catalyzed by QueF is shown in Figure 6.  The amino acid sequence homology between 
QueF and GTP cyclohydrolase I resulted in an initial mis-annotation of QueF as a GTP 
cyclohydrolase (FolE) in the sequence databases.  The QueF family possess a 
characteristic motif, named the QueF motif, E(S/L)K(S/A)hK(L/Y)(Y/F/W) where h is a 
hydrophobic amino acid bracketed on the N- and C- terminal sides by at invariant Cys 
and Glu, respectively.  The QueF motif is absent from the FolE family, while key zinc 
binding His and Cys residues found in the FolE family are absent from the QueF family; 
these differences are the best identifiers of QueF sequences in genome databases (47).   
 
Based on a homology model QueF was suggested to belong to the tunnel fold (T-fold) 
family of proteins (56).  The T-fold proteins bind substrates belonging to the purine and 
pterin families.  The T-fold family is comprised of two structural subfamilies, the 
unimodular and bimodular proteins.  The unimodular proteins possess a single T-fold 
domain and are comprised of approximately 160 amino acid residues.  The bimodular 
proteins however possess tandem T-fold domains and are comprised of approximately 
280 amino acid residues (57).  Functional assembly consists of 2 barrels face-to-face; 
some structures of the T-fold proteins are shown in Figure 7. 
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Substrate binding occurs at the interface of subunits and is anchored by a conserved Glu 
/Gln; the presence of Glu/Gln in the active site is characteristic of T-fold proteins (57).  
In dihydroneopterin aldolase (Glu74), 6- pyruvoyl tetrahydropterin synthase (Glu 107), 
and urate oxidase (Gln 228), the conserved Glu/Gln is positioned such as to serve as an 
acceptor for the pyrimidine ring of the substrate (57).  In all of these examples, the 
conserved Glu/Gln forms two hydrogen bonds to the substrate (57).  
 
The discovery of QueF activity added a novel class of chemistry to nitrile metabolism 
(Figure 8).  The other pathways currently known in nitrile metabolism involve hydrolysis 
by nitrile hydratase and nitrilase, and oxidation by oxygenase to give cyanohydrins (58).   
 
1.5 S-Adenosylribosylmethionine:tRNA ribosyl transferase isomerase (QueA) 
QueA catalyzes the penultimate step in the biosynthesis of queuosine, an unprecedented 
transfer and isomerization of the ribosyl moiety from S-adenosylmethionine (AdoMet) to 
preQ1-tRNA to give epoxyqueuosine modified tRNA, oQ-tRNA (Figure 10).  The 
reaction is accompanied by the rearrangement of the ribosyl moiety and the elimination 
of methionine and adenine (50, 59).   
 
Kinetic analysis revealed that QueA follows an ordered sequential bi-ter mechanism in 
which preQ1-tRNA binds to the enzyme followed by AdoMet to form a ternary complex, 
followed by the transfer of the ribosyl group to preQ1 and release of products in the order 
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adenine, methionine and oQ-tRNA (Figure 11) (60).  The regiochemistry of the C-N 
bond formation between preQ1-tRNA and AdoMet has been elucidated through the 
utilization of [1´-13C] AdoMet in the QueA reaction followed by the identification of the 
isotopically enriched carbon in the oQ nucleoside (61).  NMR data supports C-3 as the 
site of enrichment, implicating C-4´ of AdoMet as the site of C-N bond formation.   
 
Two possible mechanisms are implicated, consistent with C-N bond formation at C4´.  In 
the mechanism (A) proposed for the reaction catalyzed by QueA (Figure 12) the first step 
of the mechanism involves the deprotonation of AdoMet at C-5´ to give the sulfonium 
ylide I.  The subsequent opening of the ribose ring followed by elimination of adenine 
generates the vinyl sulfonium II.  Nucleophilic attack of the preQ1 methylamine at the C-
4´ position generates the sulfonium ylide III which subsequently attacks the C-1´ 
aldehyde to give the alkoxy-cabocycle IV.  Intramolecular SN2 attack of the alkoxy 
oxygen on the adjacent carbon results in the formation of oQ-tRNA and the elimination 
of methionine (60).  In mechanism (B) nucleophilic attack by the amine in an SN2 
reaction forms the C-N bond in the first step before the C5´ proton is removed (Figure 
12).  The elimination/addition mechanism (mechanism A) is compatible with loss of 
either proton since stereochemistry at C-5´ destroyed in the formation of the vinyl 
sulfonium II.  But, elimination/addition mechanism requires either syn or anti 
relationship between the proton removed and the C4´-O bond that is cleaved, the 
conformations are shown in Figure 13.  The conformation about the C4´-C5´ of bond 
AdoMet, indicates that the reaction would most likely favor the trans conformation, 
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resulting in the loss of the proS hydrogen, as this conformation is less sterically 
demanding than the syn conformation.  In contrast, an SN2 mechanism (mechanism B) 
requires loss of C-5´-proR proton of AdoMet due to known streochemistry of oQ and the 
stereochemical integrity of sulfonium ions. Thus, elucidating the stereochemistry of the 
proton abstraction at C-5´ should allow one to distinguish between these mechanisms. 
 
1.6 Objectives 
 
The overall objectives of the work described in this thesis were to investigate several 
enzymatic steps in the biosynthetic pathway leading to queuosine and archaeosine. The 
work focused specifically on the following: 
 
1. Methanocaldococcus jannaschii TgtA2 
The objectives of this work were to test the hypothesis that tgtA2 encodes the enzyme 
responsible for the final step of archaeosine biosynthesis, and to biochemically 
characterize the enzyme. 
 
2. NADPH 7-cyano-7-deazaguanine oxidoreductase (QueF) 
The objectives of this work were to determine the elementary rate constants in the kinetic 
mechanism of the reaction catalyzed by QueF (Figure 9), as well as identifying the rate 
limiting step(s) in this reaction.  In particular, to apply transient kinetic analyses to 
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elucidate the kinetics of substrate and cofactor binding, and the rates of thioimide 
formation reduction.  As well as the investigation of the effects of ligands on its 
quaternary structure. 
 
3. S-Adenosylribosylmethionine:tRNA ribosyl transferase isomerase (QueA) 
The objective of this work was to test two putative mechanisms for the QueA catalyzed 
reaction by elucidating the stereochemistry of deprotonation at C5´ of AdoMet. 
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2. MATERIAL AND METHODS  
2.1 General methods and materials  
Chemicals and reagents 
Buffers, salts and reagents of the highest quality grade available were purchased from 
Sigma (St. Louis, MO) unless otherwise noted.  DEPC (diethylpyrocarbonate) treated 
water was used in the preparation of all solutions for RNA related assays.  Dithiothreitol 
(DTT), isopropyl-β-D-thiogalacto-pyranoside (IPTG), kanamycin sulfate, β-NADPH (β-
Nicotinamide adenine dinucleotide phosphate), β-NADP+, DEPC and ampicillin were 
purchased from RPI Corporation (Chicago, IL).  The radiochemicals [U-14C]-glucose, [8-
14C]-guanine, [8-14C]-adenine, [U-14C]-L-glutamine and [3H]-L-asparagine were 
purchased from Moravek (Brea, CA).  Adenine, adenosine, guanosine, ATP, GTP, UTP, 
CTP, methionine, ribose-5-phosphate, phospho(enol)pyruvate trisodium salt, and the 
resins BND-cellulose, DEAE-cellulose, sephadex G25 and PEI cellulose TLC plates were 
all purchased from Sigma.  Nickel-nitrilotriacetic acid agarose (Ni2+-NTA agarose) was 
purchased from Qiagen (Valencia, CA).  Silica TLC plates, Whatman GF-B and 
Whatman P81 filter disks were purchased from Fisher Scientific (Pittsburgh, PA).  
Centricon YM-10 and Amicon Ultra YM-10 centrifugal devices, Amicon Ultra-MC spin 
filters and HA filters were from Millipore (Billerica, MA).  Dialysis cassettes were 
obtained from Pierce (Rockford, IL).  Plasmid Mini-Kits were from Fermentas (Glen 
Burnie, MD) and Qiagen.  AntiRNase was purchased from Ambion, Inc (Austin, TX).  
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Oligonucleotides were obtained from Integrated DNA Technologies (San Diego, CA).  
The Bradford dye binding reagent from BioRad (Hercules, CA) was used for protein 
determination.  All reagents for sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) and 10% acrylamide/Tris-HCl precast gels were purchased 
from BioRad.  SDS-PAGE analysis was carried out using 12% gels and visualized with 
Coomassie Brilliant Blue.  Invitrolon membranes (PDVF membranes) were from 
Invitrogen.  Gel filtration molecular weight standards were purchased from Sigma.  The 
mj1022 gene was custom synthesized by GenScript.  DNA sequencing was carried out at 
the DNA sequencing core facility at Oregon Health and Sciences University (OHSU), 
Portland, OR.  Edman degradation was carried out by the Molecular Structure Facility at 
University of California, Davis.  The LIC cloning kits containing either pET30Xa or 
pET32Xa plasmids were from Novagen.  M. jannaschii genomic DNA was kindly 
provided by Dr. Anna-Louise Reysenbach (Portland State University, Portland, OR). 
 
Instrumentation 
PCR was carried out on a GeneAmp PCR system 2400 from PerkinElmer Life Sciences.  
UV-Vis spectroscopy was performed with a Varian Cary 100 spectrophotometer 
equipped with a thermostated cell holder.  Fluorescence spectroscopy was carried out on 
a QM3 spectrofluorimeter from Photon Technology International and a Gemini XPS 
microplate spectrofluorimeter from Molecular dynamics.  HPLC was carried out using a 
Hitachi L-7100 pump system with an L-4500A photodiode array detector, and controlled 
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via the Hitachi ConcertChrome software.  Centrifugation was carried out on an Avanti J-
20 centrifuge, an LE-80K Ultra centrifuge using a Ti-60 rotor, and a Model TJ 6 
swinging bucket centrifuge, all from Beckman Coulter, Inc.  SDS-PAGE was carried out 
on a mini Protean III from BioRad.  Small molecule mass spectrometry was performed 
on a LCQ Advantage ion-trap mass spectrometer (Thermo Electron, San Jose, CA) 
equipped with an electrospray ionization (ESI) source at the BioAnalytical Shared 
Resource/Pharmacokinetics Core Facility in the Department of Physiology and 
Pharmacology at OHSU, Portland, Oregon, or on a MicroTOF-Q tandem mass 
spectrometry instrument (Bruker, Billerica, MA) utilizing ESI in the Department of 
Chemistry at Portland State University.  Radioactivity was quantified with a Beckman LS 
6500 liquid scintillation counter.  The pump used for column chromatography of RNA 
was a Model EP-1 Econo pump and Econo-column from BioRad.  An Amersham 
Biosciences Typhoon 9200 variable mode imager with ImageQuant 5.2 software was 
used for phosphorimaging.  Stopped flow experiments were carried out on both a Hi-
Tech Scientific SF 61-DX2 double mixing stopped flow spectrophotometer and Hi-Tech 
Scientific SF-61 AF single mixing stopped flow spectrophotometer.  The same 75 W 
Xenon Arc lamp was used for both spectrophotometry and spectrofluorimetery. 
 
Strains, media and growth conditions 
DH5α (F- φ80lacZ∆M15 ∆(lacZYA-argF)U169 recA1 endA1 hsdR17(rk-, mk+) phoA 
supE4 thi-1 gyrA96 relA1 tonA) (Invitrogen), NovaBlue (endA1 hsdR17 (rK12– mK12+) 
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supE44 thi-1 recA1 gyrA96 relA1 lac F′[proA+B+ lacIqZ∆M15::Tn10(TetR)] (Novagen), 
BL21 (DE3) F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 [lacI lacUV5-T7 gene1 ind1 
sam7 nin5]) (Novagen) were used for cloning or protein over-production, and were 
routinely grown in LB medium (BD Diagnostic System) at 37˚C.  Growth media were 
solidified with 15 g/L agar for the preparation of plates.  Transformation of E. coli was 
performed following standard procedures.  Ampicillin (amp, 100 µg/mL) and Kanamycin 
(kan, 50 µg/mL), were used as needed.  
 
Enzymes  
Crude aminoacyl-tRNA synthetase from E. coli, L-glutamic dehydrogenase type I from 
bovine liver, pyruvate kinase type II from rabbit muscle and bacterial alkaline 
phosphatase were purchased from Sigma as ammonium sulfate suspensions.  
Phosphoriboisomerase from torula yeast, hexokinase type F-300 from baker's yeast, 
nuclease P1 from Penicillium citrinum, venom phophodiesterase I, lysozyme, and DNase 
were purchased as lyophilized powders from Sigma and stored in 50% glycerol with the 
appropriate buffer at the recommended temperature.  PfuUltra™ DNA polymerase was 
purchased from Stratagene.  T4 DNA ligase and restriction enzymes were purchased 
from Fermentas and New England Biolabs.  Recombinant Saccharomyces cerevisiae 
adenine phosphoribosyl-transferase (APT1) was expressed from pQEAPT1 in E. coli 
BL25 (a generous gift from Dr. Milton Taylor, Indiana University).  Recombinant 5-
phosphoribosyl-1-pyrophosphate (PRPP) synthetase from Salmonella typhimurium was 
expressed from pBSR11R in E. coli JM831 (a gift from Dr. Vern L. Schramm, Albert 
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Einstein University).  Recombinant T7 polymerase was expressed from pT7-911Q in E. 
coli DH5α.  Recombinant S-adenosyl-methionine synthetase (MetK) was expressed in E. 
coli DH5α from pK8 (pK8 was a gift from Dr. G. Markham, Fox Chase Cancer Center, 
PA).   
 
T7 polymerase expression and purification 
Recombinant T7 polymerase was expressed in pT7-911Q/DH5α E. coli cells at 37 ºC in 
LB/amp.  Cells from a glycerol stock were used to inoculate 3 mL of LB/amp medium.  
After 12 hours a 1 mL aliquot was removed and used to inoculate 100 mL of LB/amp 
medium in 500 mL flasks.  The cultures were incubated at 37 ºC and 250 rpm for 12 
hours with shaking, after which 5 mL aliquots were taken and used to inoculate 500 mL 
of LB/amp medium in 2.5 L flasks.  After 3 hours of incubation at 37 ºC and shaking at 
250 rpm an optical density at 600 nm (OD600) of about 0.9 was reached and IPTG was 
added to a final concentration of 0.5 mM and the cells were grown for an additional 4 
hours.  The cells were collected by centrifugation at 7,500 x g for 15 minutes at 4 ºC and 
frozen with liquid nitrogen.  The cells were stored at -80 ºC until further use. 
 
The cells were resuspended to 250 mg/mL in 50 mM Tris-HCl (pH 8.0), 100 mM KCl, 2 
mM βME, 1 mM imidazole, and 1 mM PMSF.  Lysozyme was added to a final 
concentration of 250 µg/mL and the cells incubated at 37 ˚C for 30 minutes, followed by 
3 intervals of freeze-thaw cycles.  DNase was added to a final concentration of 10 µg/mL 
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and the cells were left at 37 ºC for an additional 30 minutes.  The cell lysate was 
centrifuged at 26,000 x g for 30 minutes after which it was filtered through a low protein 
binding 0.45 µm MCE filter.  The CFE was loaded onto a 10 mL column containing 
Ni2+-NTA agarose equilibrated in lysis buffer.  The column was washed with lysis buffer 
containing 10 mM imidazole.  The recombinant T7 polymerase was eluted with 100 mM 
imidazole in lysis buffer without PMSF.  The collected eluate was concentrated to about 
2 mL using the Amicon Ultra YM-10 and dialyzed overnight against 4 L of lysis buffer 
without PMSF, then stored at -80 ºC as a 50% glycerol stock in aliquots of 100 µl. 
 
PreQ0 semi-preparative HPLC purification 
 
PreQ0 was synthesized as previously described by Migawa (62).  PreQ0 was purified on a 
semi-preparative Luna C18 column (250 x 10 mm, 5 µm) from Phenomenex.  The preQ0 
eluted in a 20 minute run, eluting at 12.5 minutes under gradient conditions; 96% 25 mM 
NH4OAc (pH 6.0)/4% methanol for 10 minutes followed by a gradient of 96% 25 mM 
NH4OAc/4% methanol up to 85% 25 mM NH4OAc/15% methanol over 10 minutes at a 
flow rate of 4 mL/min . 
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2.2 Methanocaldococcus jannaschii TgtA2 (MjTgtA2) 
Cloning of MjTgtA2  
The Methanocaldococcus jannaschii mj1022 gene corresponding to tgtA2 was amplified 
from both genomic DNA and a custom synthesized gene (GenScript) via PCR and cloned 
with either N- or C-terminal His6-fusions using the following primers:  
Gen1022F  5’-GGTATTGAGGGTCGCATGCTCGAACCAATTG-3’ 
Gen1022R  5’-AGAGGAGAGTTAGAGCCTCAGCTTTTAACATTTC-3’ 
Syn1022F  5’-GGTATTGAGGGTCGCCATATGCTGGAACCG-3’ 
Syn1022R  5’-AGAGGAGAGTTAGAGCCGGATCCTTACG-3’  
CterF   5’-GAAAACCATATGCTGGAACCGATTGCGTACG-3’  
CterR   5’-GTGGTGCTCGAGCGATTTAACATTGCGAATATTC-3’. 
Primers for amplification of mj1022 from genomic DNA (Gen1022) and the synthetic 
gene (Syn1022) were designed for subsequent LIC cloning in pET32Xa with an N-
terminal thioredoxin-His6-fusion (Trx-His6-fusion).  The primers for amplification of the 
synthetic gene with a C-terminal His6-fusion (Cter) contained the restriction sites 
(underlined) for NdeI and XhoI to allow directional cloning into a pET30 vector.  The 
genes were amplified from genomic DNA (20 ng) or synthetic template (10 ng) with 
PfuUltra™ DNA polymerase using the following program: 95 ºC (5 minutes), 30 cycles 
of 95 ºC (30s), 60 ˚C (genomic DNA), 55 ˚C (synthetic gene, N-terminal fusion), or 57 ºC 
(synthetic gene, C-terminal fusion) (30s), and 72 ºC (2 minutes), followed by a final 
extension at 72 ºC for 10 minutes and hold at 4 ºC.  Amplification of the genes for the 
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construction of N-terminal fusions were followed by insertion of the PCR products into 
pET32Xa following the manufacturer's instructions to give pVCII-120 (native gene) and 
pVCIII-28 (synthetic gene).  Amplification of the gene for construction of the C-terminal 
fusion was followed by restriction digestion of the PCR product with NdeI/XhoI, gel 
purification (1% agarose), and ligation into NdeI/XhoI digested pET30 using T4 DNA 
ligase to give pVCIV-42.  Plasmid DNA was isolated from all three constructs and the 
primary structure of the genes confirmed by sequencing.  
 
Overexpression and purification of recombinant MjTgtA2  
The plasmids containing mjTgtA2 were transformed into E. coli BL21(DE3) for 
expression of the variously tagged recombinant proteins.  Cultures of transformed cells 
were grown at 37 ˚C in either LB/kan or LB/amp with shaking (250 rpm) until an OD600 
of 0.9 was obtained, IPTG was added to a final concentration of 0.25 mM, and the cells 
were grown for an additional 4½ hours.  The cells were collected by centrifugation at 
7,500 x g for 15 minutes at 4 ºC and frozen with liquid nitrogen.  The cells were stored at 
-80 ºC until needed. 
 
Frozen cell paste was suspended to 250 mg/mL in 50 mM HEPES (pH 7.0), 0.75 M 
NaCl, 2 mM βME, and 1 mM PMSF.  Lysozyme was added to a final concentration of 
250 µg/mL and the cells incubated at 37 ˚C for 30 minutes, followed by 3 intervals of 
freeze thaw cycles.  DNase was added to a final concentration of 10 µg/mL and the cells 
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were left at 37 ºC for an additional 30 minutes.  The cell lysate was centrifuged at 26,000 
x g for 30 minutes at 4 ˚C, and the cell-free extract recovered and filtered (0.45 µm 
MCE).  The CFE was heated at 60 ºC for 15 minutes followed by centrifugation for 20 
minutes at 20,000 x g; this cycle was repeated at 75 ºC.  The heat-treated CFE was loaded 
onto a column containing Ni2+-NTA agarose equilibrated in lysis buffer, and washed with 
10 volumes of lysis buffer containing 25 mM imidazole but without PMSF.  The Trx-
His6 fusion protein was eluted with 250 mM imidazole in lysis buffer without PMSF.  
The eluant was concentrated to 2 mL using the Amicon Ultra YM-10 and dialyzed 
overnight against 4 L of lysis buffer without imidazole or PMSF.  To remove the Trx-
His6 affinity tag the fusion protein (20 mg) was incubated with Factor Xa (20 µg) at room 
temperature in 100 mM Tris-HCl (pH 8.0), 0.5 M NaCl, 1 mM CaCl2, and 1 mM DTT for 
~20 hours.  The cleaved recombinant protein was then recovered after passing over a 
Ni2+-NTA agarose column.  
 
Edman Degradation of MjTgtA2   
To allow the N- and C-terminal recombinant fusion proteins to self-cleave the Trx-His6-
MjTgtA2 and MjTgtA2-His6 fusion constructs (~100 µg each) were incubated in 100 mM 
HEPES (pH 7.0), 0.5 M NaCl, and 2 mM BME at 4 ˚C for up to 4 weeks.  The proteins 
were then electrophoresed on a precast 10% acrylamide/Tris-HCl gel.  Electroblotting 
onto an Invitrolon membrane was carried out for 1 hour at 22 V according to the 
manufacturer’s instructions using NuPAGE transfer buffer.  The membrane was then 
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stained with Coomassie blue followed by washing with 50% methanol, air-drying, and 
specific bands analyzed by Edman sequencing. 
 
Size exclusion chromatography 
Size exclusion chromatography was used to determine the native molecular weight of 
MjTgtA2 using a BioSep-Sec-4000 column (Phenomenex) with a mobile phase of 50 mM 
phosphate (pH 7.2), 100 mM KCl and a flow rate of 1 mL/min.  The void volume (V0) 
and total bead volume (VT) were measured with blue dextran (2000 KDa) and potassium 
ferricyanide (K3[Fe(CN)6] 329 Da).  The column was calibrated with MWGF1000 
standards.  The partition coefficient (KD) values were calculated according to the 
equation (Ve-V0)/(VT-V0) where Ve is the elution volume of the protein of interest, then 
plotted vs. log MW to generate a standard curve. 
 
Cloning and overexpression of MJTGT 
The mj0436 gene corresponding to mjtgt was amplified from genomic M. jannaschii via 
PCR with PfuUltra™ DNA polymerase using the following primers:   
pET30-MJTGT-sense   5’-GGTATTGAGGGTCGCATGACTTTTGAGAT-3’ 
pET30-MJTGT-antisense  5’-AGAGGAGAGTTAGAGCCTCACTTATTTAT-3’.  
The primers were designed for subsequent LIC cloning into pET30Xa.  The genes were 
amplified from 10 ng genomic DNA using the following program: 95 ºC (5 minutes), 30 
cycles of 95 ºC (30s), 45 ºC (30s), and 72 ºC (2 minutes), followed by an extension at 72 
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ºC for 10 minutes and hold at 4 ºC.  Amplification of the gene was followed by insertion 
of the PCR product into pET30Xa following the manufacturer's instructions to give 
pVCV-39.  Plasmid DNA was isolated and the primary structure of the genes confirmed 
by sequencing. 
 
Recombinant His6-MJTGT protein was expressed in pVCV-39/E. coli BL21(DE3) cells 
at 37 ºC in LB/kan medium.  LB/kan medium (3 mL) was inoculated from a single colony 
of the cells, after 12 hours of incubation at 37 ºC; a 1 mL aliquot was used to inoculate 
100 mL of LB/kan medium.  The cultures were incubated at 37 ºC and 250 rpm for 12 
hours and a 5 mL aliquot was taken and used to inoculate 500 mL of LB/kan medium.  
After about 3 hours an OD600 of 0.9 was reached and protein over-expression was 
induced by the addition of IPTG to a final concentration of 0.25 mM.  The cell cultures 
were grown for an additional 4-5 hours when the cells were collected by centrifugation at 
7,500 x g for 15 minutes and frozen with liquid nitrogen.  The cells were stored at -80 ºC 
until further use. 
 
The cells were resuspended to a density of 250 mg/mL in 50 mM Tris-HCl (pH 8.0), 300 
mM KCl, 2 mM βME, and 1 mM PMSF.  Lysozyme was added to a final concentration 
of 250 µg/mL and the cells incubated at 37 ˚C for 30 minutes, followed by 3 intervals of 
freeze-thaw cycles.  DNase was added to a final concentration of 10 µg/mL and the cells 
were left at 37 ºC for an additional 30 minutes.  The cell lysate was centrifuged at 26,000 
x g for 30 minutes.  The CFE was filtered using a low protein-binding 0.45 µm MCE 
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syringe filter, then loaded onto 10 mL of Ni2+-NTA agarose resin equilibrated in 100 mM 
Tris-HCl (pH 8.0), 300 mM KCl, 2 mM βME, and 1 mM PMSF (buffer A).  The column 
was washed with 5 column volumes of buffer A followed by 5 column volumes of buffer 
A with 20 mM imidazole and no PMSF.  The recombinant protein was eluted with 7 
column volumes of buffer B containing 200 mM imidazole then concentrated to about 2 
mL using the Amicon Ultra YM-10 and dialyzed overnight against 4 L of 50 mM Tris-
HCl (pH 8.0), 100 mM KCl, and 1 mM DTT at 4 ºC.  The His6-MJTGT was cleaved by 
Factor Xa and purified as previously described.  The cleaved protein was stored in 50% 
glycerol in 100 µL aliquots at -80 ºC.   
 
In Vitro transcription of H. volcanii tRNASer 
An RNA 76-mer corresponding to the sequence of the H. volcanii tRNASer was 
transcribed in vitro from a template prepared from the pDF-II-42 plasmid after digestion 
with MvaI.  The H. volcanii tRNASer was synthesized in a reaction containing 80 mM 
HEPES-KOH (pH 7.5), 12 mM MgCl2, 2 mM spermidine, 50 µg/mL BSA, 40 mM DTT, 
0.01% Triton-X-100, 3 mM NTPs, 20 µg/mL template and 64 µg/mL recombinant T7 
polymerase.  The reaction was incubated at 37 ºC for 6 hours at which point the reaction 
was stopped by heating at 95 ºC for 3 minutes, followed by centrifugation at 20,000 x g 
for 10 minutes followed by precipitation with an equal volume of isopropanol.   
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Purification of the tRNASer 
The crude RNA was treated with RNase free DNase (40 Units/ml of the in vitro 
transcription) in 40 mM Tris-HCl (pH 8.0), 10 mM NaCl, 6 mM MgCl2 and 10 mM 
CaCl2, at 37 oC for 30 minutes.  The RNA oligomer was purified by continuous elution 
PAGE using the BioRad 491 Prep Cell and a 7 M urea, 10% acrylamide gel in the 
following manner:  approximately 10 mg of RNA in 50% formamide (v/v), 10 mM 
EDTA, 0.1% (w/v) xylene cyanol FF, and 0.1% (w/v) bromophenol blue were loaded 
onto the gel and the sample was electrophoresed at 300 V until the bromophenol blue was 
eluting at which point fraction collection began.  Fractions (5 mL) were collected at a 
flow rate of 1 mL/min and the elution of the RNA was monitored on Urea/PAGE gels.  
The fractions containing 76-mer were pooled and concentrated by lyophilizing to 
dryness.  The tRNA was resuspended in 3 mM sodium citrate (pH 6.3) and washed with a 
10-fold volume of 3 mM sodium citrate (pH 6.3) using the Amicon Ultra YM-10 in order 
to remove residual TBE. 
 
Preparation of preQ0-tRNASer 
PreQ0 was inserted into the tRNASer transcript by the native MJTGT.  An aliquot of 
MJTGT (10 µM) was added to a 1 mL solution containing 50 mM succinate (pH 5.5), 20 
mM MgCl2, 100 mM KCl, 2 mM DTT, 100 µM tRNASer, and 1 mM preQ0.  After 45 
minutes at 80 ºC, the reaction was terminated by the addition of one-tenth volume of 2 M 
NaOAc (pH 4.0) followed by one volume of water-saturated phenol and one fifth volume 
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chloroform:isoamyl alcohol (49:1).  After vortexing for 20s, the solution was centrifuged 
in a swinging bucket rotor at 700 x g for 20 minutes.  The aqueous phase was recovered 
and applied directly to a Quick-Sep column containing 2 mL of Sephadex G-25.  The 
sample was centrifuged at 700 x g in a swinging bucket rotor for 1½ minutes to separate 
the unreacted preQ0 and exchanged guanine from the preQ0-tRNASer.  The preQ0-tRNASer 
was precipitated from the eluate by the addition of 3 volumes of ethanol and cooling at -
20 ºC for 2 hours.  The solution was centrifuged at 20,000 x g for 20 minutes at 4 ˚C, the 
supernatant removed, and the RNA pellet washed with 70% cold ethanol.  After 
centrifugation again at 20,000 x g the supernatant solution was removed and the preQ0-
tRNASer was resuspended in 3 mM sodium citrate (pH 6.3) and stored at -20 ºC. 
 
pH and temperature dependence of MjTgtA2 activity 
The pH dependence of MjTgtA2 was investigated using the tri-buffer system composed 
of 100 mM Tris/Mes/Acetate (pH 4.0 – 9.0), 0.5 M NaCl, 20 mM MgCl2, 1 mM DTT, 10 
µM [U-14C]-L-glutamine, 20 µM preQ0-tRNASer, and MjTgtA2 (7.8 µg).  The activity of 
MjTgtA2 was also determined in several discrete buffers, including HEPES, phosphate, 
citrate, and acetate.  Assays were carried out at 40 ˚C, initiated with the addition of 
MjTgtA2, and terminated after 10 minutes with the addition of 0.2 volume concentrated 
NH4OH. 
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Quantification of [U-14C]-L-glutamate formation was carried out as described above.  
The temperature dependence of the reaction was determined in the presence of 100 mM 
HEPES (pH 7.0), 0.5 M NaCl, 20 mM MgCl2, 1 mM DTT, 10 µM [U-14C]-L-Glutamine, 
20 µM preQ0-tRNASer, and MjTgtA2 (7.8 µg).  Assays were carried out as described 
above with temperatures from 30 °C to 80 ˚C. 
 
Glutaminase assays 
Glutaminase activity was detected indirectly as a coupled assay to glutamate 
dehydrogenase under continuous conditions.  For coupled assays varying concentrations 
of MjTgtA2 were  incubated in the presence or absence of preQ0-tRNASer (10 µM) in an 
assay solution containing 50 mM phosphate (pH 7.5), 0.5 M NaCl, 15 mM MgCl2, 1 mM 
DTT, 2.5 mM Gln, 1 mM NADP+ and 4 U of glutamate dehydrogenase.  Assays were run 
at 37 ˚C with NADPH production monitored at 340 nm. 
 
Direct assays of glutaminase activity were carried out for 10 minutes in 100 mM HEPES 
(pH 7.0), 20 mM MgCl2, 0.5 M NaCl, 2 mM DTT, 12.4 µM [U-14C]-L-Gln, 50 µM 
tRNASer with varying concentrations of MjTgtA2.  The reactions were terminated by 
addition of 0.2 volume concentrated NH4OH.  A 6 µL portion of the assay was spotted 
onto silica TLC plates and the plates developed in i-PrOH:NH4OH(conc) (7:3).  The 
plates were then analyzed on the Typhoon 9200. 
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Amidotransferase assays 
Assays of amidotransferase activity were carried out in 100 mM HEPES (pH 7.0), 0.5 M 
NaCl, 20 mM MgCl2, 1 mM DTT, 10 µM MjTgtA2, 50 µM preQ0-tRNASer in the 
presence of the 3 possible donors, NH4Cl (100 mM), Gln (5 mM) or Asn (5 mM).  The 
reaction was carried out at 40 ºC and stopped by the addition of 0.1 volume of 2 M 
NH4OAc (pH 4.0) followed by one volume of water-saturated phenol and 0.2 volume 
chloroform:isoamyl alcohol (49:1).  After vortexing for 20s, the solution was centrifuged 
in a swinging bucket rotor at 700 x g for 20 minutes.  The aqueous phase was recovered 
and the product G+-tRNASer was precipitated with 3 volumes of ethanol and placed at -20 
ºC for 2 hours.  The solution was centrifuged at 20,000 x g for 20 minutes at 4 ˚C, the 
supernatant removed, and the RNA pellet washed with 70% cold ethanol.  The solution 
was centrifuged again at 20,000 x g for 20 minutes at 4 ºC, the supernatant removed, and 
the RNA was resuspended to 3 µg/µL in H2O and digested as previously described (63). 
Nucleosides were analyzed by HPLC using a Discovery HS C18 column (2.1 mm x 250 
mM, Supelco), with a mobile phase comprised of a linear gradient from 100% 5 mM 
NH4OAc (pH 5.3) to 85% 5 mM NH4OAc/15% acetonitrile developed over 30 minutes at 
0.3 mL/min. 
 
LCMS analysis of nucleosides was performed on a MicroTOF-Q tandem mass 
spectrometry instrument (Bruker, Billerica, MA) utilizing electrospray ionization (ESI). 
The ESI interface was operated in the positive mode using the following settings: end 
plate offset −500 V, capillary voltage −4500 V, nebulizer gas 1.6 bar, dry gas 4 L/min, 
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dry temperature 200˚C, funnel 1 RF 350 Vpp, funnel 2 RF 350 Vpp, hexapole RF 
400 Vpp, collision energy 10 eV and collision RF 300 Vpp. 
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2.3 NADPH 7-cyano-7-deazaguanine oxidoreductase 
 
Expression and purification of wild type His6-QueF, His6-C55A and His6-E78A 
mutants  
Recombinant QueF (ykvM) was expressed in E. coli BL 21(DE3) cells with the plasmid 
pET30-ykvM in LB/kan medium.  The frozen cell stock was used to inoculate 3 mL of 
LB/kan medium.  After 12 hours of incubation at 37 ºC, a 1 mL aliquot was removed and 
used to inoculate 100 mL of LB/kan medium in a 500 mL flask.  The cultures were 
incubated at 37 ºC and 250 rpm for 12 hours and 5 mL aliquots were removed and used to 
inoculate 500 mL of LB/kan medium in 2.5 L flasks.  When an OD600 of 0.9 was reached, 
protein over-expression was induced by the addition of IPTG to a final concentration of 
0.5 mM.  The cell cultures were grown for an additional 4 hours at which time the cells 
were collected by centrifugation at 7,500 x g for 10 minutes at 4 ºC and frozen with liquid 
nitrogen.  Typically 20 g of cells were obtained from 4 L of media.  The cells were stored 
at -80 ºC until further use.  The expression of the mutants was carried out as described for 
the wild-type protein. 
 
The cells were resuspended to a density of 250 mg/mL in 100 mM Tris-HCl (pH 8.0), 
100 mM KCl, 1 mM βME, and 1 mM PMSF.  Lysozyme was added to a final 
concentration of 250 µg/mL and the cells incubated at 37 ˚C for 30 minutes, followed by 
3 intervals of freeze thaw cycles.  DNase was added to a final concentration of 10 µg/mL 
and the cells were left at 37 ºC for an additional 30 minutes.  The cell lysate was 
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centrifuged at 26,000 x g for 30 minutes.  The CFE was filtered using a low protein-
binding 0.45 µm MCE syringe filter, then loaded onto 10 mL of Ni2+-NTA agarose resin 
equilibrated in 100 mM Tris-HCl (pH 8.0), 100 mM KCl, 1 mM βME, and 1 mM PMSF 
(buffer A).  For all the mutants only 2 mL of the Ni2+-NTA agarose was used.  The 
columns were washed with: 5 column volumes buffer A followed by 5 column volumes 
buffer A with 20 mM imidazole (buffer B) and finally with 5 column volumes of buffer 
A with no PMSF but with 50 mM imidazole (buffer C).  The recombinant fusion proteins 
were eluted with 5 column volumes of buffer C containing 200 mM imidazole (Buffer D) 
to about 2 mL using the Amicon Ultra YM-10 and dialyzed overnight against 4 L of 100 
mM Tris-HCl (pH 8.0), 100 mM KCl, and 1 mM DTT at 4 ºC (Buffer E).  Following 
dialysis the recombinant fusion proteins were treated with Factor Xa. 
 
Purification of QueF proteins 
Factor Xa (10 µg) was added to 20 mg of purified QueF protein and the digestion was 
carried out in the presence of 100 mM Tris-HCl (pH 8.0), 100 mM KCl, 1 mM CaCl2, 
and 1 mM βME.  The digestion was carried out for 20 hours at room temperature after 
which the digestion reaction was loaded onto a Ni2+-NTA agarose column that had been 
equilibrated in 100 mM Tris-HCl (pH 8.0), 100 mM KCl, and 1 mM βME (Buffer F).  
The cleaved wild type protein was eluted with 5 column volumes of buffer F.  The 
protein was concentrated as previously described and stored in aliquots of 100 µL at - 80 
ºC in the presence of 50% glycerol.  The same procedure was repeated for the mutants. 
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Preparation of glassware for metal analysis and apoprotein preparation 
Glassware and plasticware to be used in the analysis was soaked in 10% nitric acid for 48 
hours.  This was followed by repeated soaking in 5 mM EDTA for 2 hours in the 
presence of chelex resin (3x total).  Chelex-treated water was used for the preparation of 
all the buffers and salts for the apoprotein preparation as well as the subsequent analysis.  
Native QueF was dialyzed against 4 L of 100 mM Tris-HCl (pH 8.0), 0.5 M KCl, 1 mM 
βME, 10 mM EDTA, and 2 g of chelex for 24 hours.  This was followed by a second 
dialysis in the presence of 2 L 100 mM Tris-HCl (pH 8.0), 200 mM KCl, 1 mM βME, 
and 1 g chelex for 24 hours.  The final dialysis was carried out in 2 L of 100 mM Tris-
HCl (pH 8.0), 100 mM KCl, and 1 mM βME for 2 hours. 
 
Determination of the effect of metals on QueF activity 
The activity of the native QueF was determined in the presence of Mn2+, Cu2+, Ca2+, Zn2+ 
and Mg2+, and in the presence of EDTA.  The concentration of the metals was varied from 
0 to 10 mM.  The reaction conditions were 100 mM Tris-HCl (pH 7.5), 100 mM KCl, 1 
mM DTT, 80 µM NADPH, 150 µM preQ0, 1 µM QueF, and the divalent metal (varied).  
The reactions were carried out at 30 ºC and monitored by following the depletion of 
NADPH at 340 nm. 
 
The effect of KCl concentration on QueF activity was determined on both the native and 
"apparent apoprotein".  Three concentrations of KCl were tested, 10 mM, 50 mM and 
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100 mM.  The reaction conditions were 100 mM Tris-HCl pH (7.5), 1 mM DTT, 80 µM 
NADPH, 150 µM preQ0, 250 µM MnCl2, 1 µM QueF, and KCl (varied). 
 
pH profile determination 
The effect of pH on the activity of QueF was examined using the following buffers; MES 
(pH 5.75 - 6.67), Tris-HCl (pH 7.0 - 8.0), and potassium phosphate (5.8 - 8.0).  The 
following reaction conditions were used: 100 mM Buffer, 50 mM KCl, 1 mM DTT, 80 
µM β-NADPH, 100 µM preQ0, 2 µM QueF, and 250 µM MnCl2.  The reactions were 
carried out at 30 ºC and initiated by QueF addition in a final volume of 200 µL. The 
reaction was monitored by following the depletion of NADPH at 340 nm. 
 
Size exclusion chromatography   
Size exclusion chromatography was used to determine the effect of ligands and salts on 
the quaternary structure of QueF using a BioSep-Sec-4000 column (Phenomenex) with a 
mobile phase of 25 mM phosphate (pH 7.2), 25 mM KCl, and a flow rate of 1 mL/min.  
The change in the retention time of QueF was analyzed in the presence of MnCl2 or 
MgCl2, varying concentrations at KCl and in the presence of preQ0.  The QueF was 
incubated with preQ0 at least 10 minutes before analysis.  However, for analyzing the 
effect of KCl on quaternary structure the protein was incubated for 3 hours in the 
presence of 0.5 M KCl and 10 mM EDTA, and the KCl effect was determined using a 
mobile phase of 25 mM phosphate (pH 7.2), 0.5 M KCl. 
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Development of fluorescence assays for use in stopped flow kinetics 
 
Fluorescence of the single tryptophan residue of QueF was determined by excitation at 
295 nm and emission between 305 - 450 nm.  The fluorescence was determined in the 
presence of 50 mM phosphate (pH 6.5), 50 mM KCl, 1 mM DTT, 250 µM MnCl2, 80 µM 
QueF, and 100 µM preQ0 and without preQ0.  Fluorescence of NADPH was determined 
in the presence of QueF and preQ0 by excitation at 340 nm and the emission from 360 nm 
to 700 nm.  
 
Transient kinetics 
Rapid kinetic studies were performed using a double-mixing Hi-Tech Scientific 
(Salisbury, Wiltshire, UK) model SF-61 DX2 stopped-flow spectrophotometer/ 
fluorimeter controlled by KinetAsyst (version 3.16; Hi-Tech Scientific).  Fluorescence 
and absorbance measurements were determined in single mixing mode (observation cell 
optical path-length of 1 cm), equipped with a 75 W short arc mercury lamp.  Some of the 
absorbance based kinetics experiments were also performed on a Hi-Tech Scientific SF-
61 AF single mixing stopped flow spectrophotometer.  The reactions were carried out 
with a final volume of 120 µL from solutions driven from high performance syringes 
through a high efficiency mixer.  The resultant mixture passed through the measurement 
flow cell and into a stopping syringe.  Steady flow of the mixture was achieved just 
before stopping.  A schematic of a stopped flow instrument is shown in Figure 15.  
Temperature was controlled using a circulating waterbath.  Apparent rate constants (kobs) 
36 
 
from kinetic traces were calculated using the KaleidaGraph software and rate constants 
were determined by use of Dynafit through global analysis of the data.  
 
Thioimide formation 
The kinetics of formation of the thioimide between QueF and preQ0 were measured using 
stopped-flow spectrophotometry.  One syringe was filled with solution A (124 µM QueF, 
50 mM potassium phosphate (pH 6.5), 50 mM KCl, 250 µM MnCl2, and 1 mM DTT), 
whereas the second syringe was filled with solution B (i.e. solution A without QueF).  
Equal volumes (60 µL each) of solution A were mixed with solution B.  Five or more 
shots were performed to flush the stopped-flow lines and to obtain a baseline.  After the 
flushing was complete, the solution B in the second syringe was replaced with solution B 
containing preQ0 (solution C), and several shots were performed with varying 
concentrations of preQ0.  The final concentrations of preQ0 in the reactions were 11.8, 
17.0, 21.5, 26.3, 37.7, 51.0 µM, and QueF final concentration was 62 µM.  The reactions 
were carried out at 30 ºC and monitored at 370 nm for 5 seconds.  The data was fit to 
single and double exponential rise equations using KaleidaGraph; 
 
y = A(1-exp(-kobst)) + a 
y = A1 (1-exp(-kobs1t)) + A2(1-exp(-kobs2t)) + a 
37 
 
where y is the absorbance signal, A, A1, A2, are the amplitudes, a is the offset, and kobs, 
kobs1 and kobs2 are apparent rate constants.  Global data analysis was also carried out using 
DynaFit (Equations).  The rates of the spectral changes at 370 nm were obtained from the 
best fits with the smallest residuals. 
 
Transient kinetics of substrate binding 
PreQ0 binding to wild-type and C55A QueF was measured using stopped-flow 
fluorescence spectroscopy by monitoring the intrinsic tryptophan fluorescence under 
pseudo first order conditions, where the QueF concentration was maintained high and 
preQ0 concentration was varied. The excitation wavelength was 295 nm, and emission 
was observed at 334 nm (a 334±5 nm band pass emission filter was used, Edmund Optics 
Inc, USA).  For each experimental condition 12 shots were carried out and averaged.  The 
fluorescence of the QueF solution without preQ0 was measured before the 
commencement of the experiment and was set as the 100% fluorescent signal.  The 
reactions were carried out at 20 ºC in the presence of 50 mM potassium phosphate buffer 
(pH 6.5), 50 mM KCl, 250 µM MnCl2, and 1 mM DTT.  For the analysis of preQ0 
binding to wild type QueF the final concentrations in reactions were 200 µM QueF and 
preQ0 (5.3, 15.4, 22.6, 30.4 µM).  PreQ0 binding to C55A was determined in the presence 
of 200 µM QueF, and preQ0 (6.8, 11.8, 18.2, 23.3, 29.2, 38.8, 50.0 µM).  The QueF 
concentration was kept high and the preQ0 concentration was varied.  At least 512 points 
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were collected in each trace.  The data was fit to single and double exponential decay 
equations using KaleidaGraph; 
y = Aexp(-kobst) + a 
y = A1exp(-kobs1t) + A2exp(-kobs2t) + a 
where y is the absorbance signal, A, A1, A2, are the amplitudes, a is the offset, and kobs, 
kobs1 and kobs2 are apparent rate constants.  Global analysis was again carried out using 
Dynafit. 
 
NADPH binding kinetics were also determined for the QueF mutant, E78A, which is 
capable of forming the thioimide bond but unable to facilitate its reduction.  The binding 
was directly monitored by following the intrinsic NADPH fluorescence with excitation at 
340 nm and emission was monitored by using a 455 nm long pass filter.  The reaction 
was carried out at 20 ºC, 50 mM potassium phosphate buffer (pH 6.5), 50 mM KCl, 250 
µM MnCl2, and 1 mM DTT.  The E78A QueF mutant (200 µM) was preincubated with 
700 µM preQ0 for at least 10 minutes before mixing with varying concentrations of 
NADPH.  The final concentrations of NADPH in the assays were; 16.0, 23.5, 31.8, 39.4, 
50.3, 57.4, 69.3 µM, and the E78A QueF-*PreQ0 was 100 µM. 
Transient kinetics of thioimide reduction 
Reduction of the thioimide bond was monitored under single turnover conditions by 
using both the intrinsic NADPH fluorescence with excitation at 340 nm and the emission 
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was monitored by using a 455 nm long pass filter as well as by monitoring the loss of the 
thioimide absorption at 390 nm.  The change in signal was monitored upon rapid mixing 
of equal volumes of premixed QueF-*PreQ0 solution from one syringe and varying 
concentrations of NADPH from the second syringe.  For the fluorescence analysis the 
reaction was carried out at 20 ºC in 50 mM potassium phosphate buffer (pH 6.5), 50 mM 
KCl, 250 µM MnCl2, and 1 mM DTT.  QueF was (145 µM) was preincubated with 300 
µM preQ0 for at least 10 minutes before mixing with varying concentrations of NADPH.  
The final concentrations of NADPH in the assay were 8; 16, 23.5 µM, and the QueF-
*PreQ0 was 72.5 µM.  For absorbance assays the reaction was carried out at 30 ºC in 50 
mM potassium phosphate buffer (pH 6.5), 50 mM KCl, 250 µM MnCl2, and 1 mM DTT, 
with final concentration of QueF-*PreQ0 at 180 µM in the presence of 20 and 26.3 µM 
NADPH.  
 
Thioimide decomposition 
Thioimide decomposition was monitored at 370 nm at 30 ºC on the Cary 100 
spectrophotometer.  The reactions were carried out in the presence of 50 mM potassium 
phosphate buffer (pH 6.5), 50 mM KCl, 250 µM MnCl2, 1 mM DTT, ~ 154, 158 and 161 
µM QueF-*PreQ0.  For the preparation of the thioimide 1 mL of 200 µM QueF and 600 
µM preQ0 were mixed and incubated for at least 10 minutes before the excess preQ0 was 
removed by either dialysis against 4 L of 50 mM phosphate (pH 6.5), 50 mM KCl, 250 
µM MnCl2, and 1 mM DTT or by 3 consecutive buffer exchanges with the dialysis buffer 
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resulting in a 1000 times dilution.  The resulting covalent QueF-*PreQ0 complex was 
then monitored for at least 8 hours with either 5 or 10 minute intervals using multiple 
scanning kinetics. 
 
 
 
41 
 
2.4 S-Adenosylribosylmethionine:tRNA ribosyl transferase isomerase  
Expression and purification of His6-QueA  
Recombinant QueA was expressed in pET30-QueA/BL21(DE3) E. coli cells at 37 ºC in 
LB/kan medium.  Cells from a glycerol stock were used to inoculate 3 mL of LB/kan 
medium.  After 12 hours a 1 mL aliquot was removed and used to inoculate 100 mL of 
LB/kan medium in 500 mL flasks.  The cultures were incubated at 37 ºC and 250 rpm for 
12 hours, after which 5 mL aliquots were taken and used to inoculate 500 mL of LB/kan 
media in 2.5 L flasks.  After 3½ hours of incubation at 37 ºC with shaking at 250 rpm an 
OD600 of about 0.9 was reached, IPTG was added to a final concentration of 0.2 mM, and 
the cells were grown for an additional 4 hours.  The cells were collected by centrifugation 
at 7,500 x g for 15 minutes at 4 ºC and frozen with liquid nitrogen.  The cells were stored 
at -80 ºC until further use. 
 
Cells were resuspended to a density of 250 mg/mL in 50 mM Tris-acetate buffer (pH 
8.0), 50 mM KCl, 2 mM βME, and 1 mM PMSF.  The cells were lysed by the addition of 
lysozyme to a final concentration of 250 µg/mL and lysis was carried out for 30 minutes 
at 37 ºC.  After which, one-fourth volume of chilled 400 mM Tris-acetate (pH 8.0), 1.2 M 
KCl, 8 mM βME, 4 mM PMSF, 4% Triton-X-100 and 40% glycerol was added to the 
mixture and placed on ice for 5 minutes.  The cell lysate was centrifuged at 26,000 x g for 
30 minutes at 4 ºC, after which the CFE was filtered through a 0.45 µm MCE syringe 
filter. 
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The CFE was loaded onto a column containing 10 mL of Ni2+-NTA agarose resin 
equilibrated in 100 mM Tris-acetate (pH 8.0), 300 mM KCl, 2 mM βME, 1% Triton-X-
100 and 10% glycerol (buffer A).  The column was washed with 5 column volumes 
buffer A followed by 5 column volumes of buffer A with 20 mM imidazole (buffer B) 
and finally by 5 column volumes of buffer B without the triton X-100 or PMSF (buffer 
C).  Protein elution was carried out with 7 column volumes of buffer C containing 200 
mM imidazole (buffer D).  The protein was concentrated to about 1 mL using an Amicon 
Ultra YM-10 and dialyzed overnight against 4 L of 50 mM Tris acetate (pH 8.0), 50 mM 
KCl, and 1 mM DTT at 4 ºC.  The protein determination was carried out using the 
Bradford method and protein purity was verified by use of SDS-PAGE.  The protein was 
stored in aliquots of 100 µL at - 80 ºC in the presence of 50% glycerol. 
 
Assays for QueA activity were carried out in 100 mM Gly-gly (pH 8.7), 100 mM EDTA 
(pH 8.7), 100 mM KCl, 1 mM DTT, and 20 µM tRNATyr, 200 µM [U-ribosyl-14C]-
AdoMet and 1 µM QueA.  The reactions were carried out in 50 µL volumes and 
terminated by the addition of 4 volumes of 10% TCA and left to stand on ice for at least 
ten minutes before collecting the precipitated tRNA on Whatman GF-C fibers by vacuum 
filtration.  The filters were washed with at least a liter of 5% TCA followed by 95% 
ethanol, air dried and the radioactivity quantified by liquid scintillation counting 
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Expression and purification of E. coli tRNA-Guanine Transglycosylase (TGT) 
The recombinant E. coli TGT was expressed in E. coli BL21(DE3) with the plasmid 
pET30-Ectgt in LB/kan medium.  Cells from a frozen glycerol stock were used to 
inoculate 3 mL of LB/kan medium.  After 12 hours of incubation at 37 ºC, 1 mL aliquot 
was used to inoculate 100 mL of LB/kan medium.  The cultures were incubated at 37 ºC 
and 250 rpm for 12 hours and 5 mL aliquot was taken and used to inoculate 500 mL of 
LB/kan medium.  After about 3 hours an OD600 of 0.9 was reached and protein over-
expression was induced by the addition of IPTG to a final concentration of 0.2 mM.  The 
cell cultures were grown for an additional 4-5 hours, after which the cells were collected 
by centrifugation at 5,000 x g for 15 minutes and frozen with liquid nitrogen.  The cells 
were stored at -80 ºC until further use. 
 
The cells were resuspended to a density of 250 mg/mL in 50 mM Tris-acetate (pH 7.5), 
50 mM KCl, 2 mM βME, and 1 mM PMSF.  Lysozyme was added to a final 
concentration of 250 µg/mL and the cells incubated at 37 ˚C for 30 minutes, followed by 
3 intervals of freeze thaw cycles.  DNase was added to a final concentration of 10 µg/mL 
and the cells were left at 37 ºC for an additional 30 minutes.  The cell lysate was 
centrifuged at 26,000 x g for 30 minutes.  The CFE was filtered using a low protein-
binding 0.45 µm MCE syringe filter, then loaded onto 10 mL of Ni2+-NTA agarose resin 
equilibrated in 100 mM Tris-acetate (pH 7.5), 300 mM KCl, 2 mM βME, 4 mM PMSF, 
1% Triton X-100, and 10% glycerol ( buffer A).  The column was washed with 5 column 
volumes buffer A with 20 mM imidazole (buffer B) followed by 5 column volumes 
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buffer B with no Triton X-100 or PMSF (buffer C).  The fusion protein was eluted with 7 
column volumes of buffer C containing 200 mM imidazole (buffer D), then concentrated 
to about 2 mL using the Amicon Ultra YM-10 and dialyzed overnight against 4 L of 50 
mM Tris-acetate (pH 7.5), 50 mM KCl, and 2 mM DTT at 4 ºC.  The protein was stored 
in the presence of 50% glycerol in 100 µL aliquots at -80 ºC.  Activity was measured as 
previously described (48).  
 
Adenine phosphoribosyltransferase (APRTase) expression and purification 
Recombinant APRTase was expressed from pQE-APT1 in E. coli B25 cells as a His-
tagged protein.  Cell cultures were grown at 37 ºC in 2xYT medium containing 100 
µg/mL ampicillin and 25 µg/mL kanamycin.  The cells were grown in 3 mL cultures at 
37 ºC for 12 hours and 250 rpm, after which 1 mL was taken and used to inoculate 100 
mL of 2xYT/kan/amp medium and left to grow for another 12 hours.  Erlenmeyer flasks 
containing 500 mL of 2xYT/kan/amp medium were inoculated with 5 mL of the 100 mL 
culture and left to grow until the OD600 had reached about 0.9 at which point the protein 
over-expression was induced by the addition of 0.25 mM IPTG.  The cell cultures were 
left to grow for an additional 4 hours after which they were harvested by centrifugation at 
7,500 x g for 15 minutes and frozen immediately with liquid nitrogen.  The cells were 
stored at -80 ºC until further use.  Approximately 14 g of cells were obtained from 4 L of 
cell culture. 
 
45 
 
The cells were resuspended to a final density of 250 mg/mL in lysis buffer of 50 mM 
Tris-HCl (pH 7.4), 5 mM MgCl2 and 20 mM KCl.  Lysozyme was added to a final 
concentration of 250 µg/mL and the cells incubated at 37 ˚C for 30 minutes, followed by 
3 intervals of freeze thaw cycles.  DNase was added to a final concentration of 10 µg/mL 
and the cells were left at 37 ºC for an additional 30 minutes.  The cell lysate was 
centrifuged at 26,000 x g for 30 minutes.  The CFE was filtered using a low protein-
binding 0.45 µm MCE syringe filter, then loaded onto 10 ml of Ni2+-NTA agarose resin, 
which had been previously equilibrated in lysis buffer.  The column was washed with 10 
column volumes of lysis buffer containing 50 mM imidazole followed by elution with 4 
column volumes using lysis buffer containing 150 mM imidazole.  The protein was 
concentrated using an Amicon Ultra YM-10 centrifugal device at 4 ºC.  The sample was 
dialyzed overnight against 4 L of the same buffer without imidazole and stored as a 50% 
glycerol stock.  Protein purity was confirmed by SDS-PAGE. 
 
The activity of the purified protein was assayed in a solution containing, 50 mM Tris-HCl 
(pH 7.0), 8 mM MgSO4, 1 mg/mL BSA, 200 µM [8-14C]Adenine, 5 µg/mL of PRPP, and 
2 µg APRTase.  The assay was carried out at room temperature in 100 µL reaction 
volume and the formation of AMP was monitored by the removal of 15 µl aliquots, 
quenching with the addition of EDTA to a final concentration of 100 mM and applied 
onto DE-81 filters.  The filters were washed with distilled water and placed in vials with 
scintillation fluid and counted. 
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5-phosphoribosyl-1-pyrophosphate (PRPP) synthetase expression and purification 
E. coli cells JM831 containing the pBSR11R plasmids were expressed in LB/amp 
medium at 37 ºC.  Cells from a glycerol stock were used to inoculate 3 mL of LB/amp 
medium and were grown for 12 hours at 37 ºC and 250 rpm, after which 1 mL was taken 
and used to inoculate 100 mL LB/amp medium and left to grow for 12 hours at 37 ºC at 
250 rpm.  Erlenmeyer flasks containing 500 mL of LB/amp medium were inoculated with 
5 mL of the 100 mL culture and left to grow at 37 ºC and 250 rpm until the OD600 had 
reached about 0.9 at which point the protein expression was induced by the addition of 
0.25 mM IPTG.  The cell cultures were left to grow for an additional 4 hours after which 
they were harvested by centrifugation at 5,000 x g for 15 minutes and frozen immediately 
with liquid nitrogen.  The cells were stored at -80 ºC until further use.  Approximately 20 
g of cells were obtained from 3.5 L of cell culture. 
 
The cells were resuspended to a final concentration of 250 mg/mL in 50 mM potassium 
phosphate (pH 7.5), 2 mM DTT, and 1 mM PMSF.  Lysozyme was added to a final 
concentration of 250 µg/mL and the cells incubated at 37 ˚C for 30 minutes, followed by 
3 intervals of freeze thaw cycles.  DNase was added to a final concentration of 10 µg/mL 
and the cells were left at 37 ºC for an additional 30 minutes.  The cell lysate was 
centrifuged at 26,000 x g for 30 minutes.  The CFE was filtered using a low protein-
binding 0.45 µm MCE filter.  The PRPP synthetase was precipitated out by slow addition 
of small amounts of ammonium sulfate over an hour to a final concentration of 15% with 
constant swirling.  The precipitated protein was left to stand on ice for an additional 30 
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minutes after which it was pelleted by centrifugation at 26,000 x g for 30 minutes at 4 ºC.  
The pellet was resuspended in an equal volume of the lysis buffer used to suspend the E. 
coli cells used to prepare the lysate, and the protein was concentrated using an Amicon 
Ultra YM-10 centrifugal device at 4 ºC.  The sample was dialyzed overnight and against 
the same buffer and stored as a 50% glycerol stock.  Activity was assessed as previously 
described (64). 
 
S-adenosylmethionine synthetase (MetK) expression and purification 
Recombinant MetK was over-expressed from E. coli DH5α/pK8.  Cell cultures were all 
grown at 37 ºC in LB/amp medium.  Cells from a glycerol stock were used to inoculate 3 
mL of LB/amp medium and were grown for 12 hours at 37 ºC and 250 rpm, after which 1 
mL was taken and used to inoculate 100 mL LB/amp medium and left to grow for 12 
hours at 37 ºC at 250 rpm.  Erlenmeyer flasks containing 500 mL of LB/amp medium 
were inoculated with 5 mL of the 100 mL culture and left to grow at 37 ºC and 250 rpm 
until the OD600 had reached about 0.8 at which point the protein expression was induced 
by the addition of 1 mM IPTG.  The cells were harvested by centrifugation at 5,000 x g 
for 10 minutes, after which they were frozen with liquid nitrogen.  About 12 g of cells 
were obtained from 3.5 L of media. 
 
The cells were resuspended in 50 mM Tris-HCl (pH 8.0), 0.5 mM EDTA and 1 mM 
PMSF.  Lysozyme was added to a final concentration of 250 µg/mL and the cells 
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incubated at 37 ˚C for 30 minutes, followed by 3 intervals of freeze thaw cycles.  DNase 
was added to a final concentration of 10 µg/mL and the cells were left at 37 ºC for an 
additional 30 minutes.  The cell lysate was centrifuged at 26,000 x g for 30 minutes.  The 
cell-free extract was filtered by a low protein binding 0.45 µm MCE syringe filter.  MetK 
was precipitated with ammonium sulfate at a final concentration of 65%.  The 
precipitated enzyme was collected by centrifugation and resuspended in 50 mM Tris-HCl 
(pH 8.0), 0.5 mM EDTA (pH 8.0), and 1 mM PMSF and concentrated to about 2 mL 
using the Amicon YM-10.  The protein was dialyzed overnight against 4 L of lysis buffer 
and stored in 50% of glycerol at -80 ºC.  
  
Protein activity was assayed by monitoring the conversion of [1-14C-]-L-methionine and 
ATP to [1-14C-]-AdoMet.  The reaction conditions were 100 mM Tris-HCl (pH 8.0), 100 
mM KCl, 10 mM MgCl2 and 2 mM [1-14C-]-L-methionine.  The reactions were carried 
out at room temperature for 1 hour and stopped by addition of 100 mM EDTA.  The 
reaction mixture was placed on Whatman p-81 filters and washed with at least 500 mL of 
distilled water before being placed in scintillation vials and counted. 
 
Preparation and purification of [U-ribosyl-14C] ATP  
Synthesis of [U-ribosyl-14C]-ATP was carried by using 7 commercially available 
enzymes and 2 in-house purified enzymes and [U-14C]-glucose.  The synthesis was 
carried out as previously described (65, 66) with a few modifications.  A single reaction 
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mixture of 1 mL contained 200 µM [U-14C]-glucose, 50 mM potassium phosphate (pH 
7.5), 50 mM gly-gly (pH 8.7) , 10 mM MgCl2, 3 mM adenine, 20 mM PEP, 1 mM 
NADP+, 1 mM ATP , 10 mM α-ketoglutarate, 0.8 U of glusoe-6-phosphate dehydroge-
nase, 0.8 U of phosphogluconate dehydrogenase, 8 U of phosphoribisomerase, 100 µg of 
5-phosphoribosyl-1-pyrophosphate synthetase, 25 µg of adenine phosphoribosyltrans-
ferase, 8 U of myokinase, 16 U of pyruvate kinase and 8 U of hexokinase.  All these 
enzymes were combined and washed with 10 ml of 10 mM phosphate buffer (pH 7.5) and 
concentrated in a Centricon YM-10 unit to remove salts.  Glutamate dehydrogenase was 
added to provide a final concentration of 50 mM NH4+ required as a substrate by 
glutamate dehydrogenase.  The reaction was carried out at 37 ºC for about 4 hours, and 
was monitored by TLC analysis on PEI cellulose, which was cut into 1 cm strips as the 
reaction proceeded.  The reaction was terminated by heating to 95 ºC for 3 min followed 
by centrifugation at 20,000 x g for 20 minutes. 
 
Purification of [U-ribosyl-14C]ATP was carried out on a C18 reverse-phase HPLC with a 
semi preparative Hypersil 5 C18 column (250 x 10 mm, 5 µm, phenomenex) (66).  The 
ATP was eluted under isocratic conditions of 94% 83.3 mM triethylammonium acetate 
(pH 6.0)/6% methanol at a flow rate of 4 mL/min.  The ATP fractions were pooled and 
lyophilized to dryness and dissolved in water.  The concentration of ATP was determined 
by UV spectroscopy at 260 nm (ε260 = 15.4 x 103 M-1 cm-1). 
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Synthesis and purification of unlabelled and [U-ribosyl-14C]-AdoMet 
The purified [U-ribosyl-14C]-ATP was used in an enzymatic step to produce [U-ribosyl-
14C]-Adomet (67).  The reaction was carried out in 100 mM Tris-HCl (pH 8.0), 50 mM 
KCl, 26 mM MgCl2, 5 mM DTT, 5 mM methionine, 1 mM [U-ribosyl-14C]-ATP, 20% 
acetonitrile, and 1.0 mg/mL of MetK.  The reaction was monitored as previously 
described.  The reaction was terminated by the addition of cold tricholoroacetic (TCA) 
acid to a final concentration of 8% (w/v).  After centrifugation at 20,000 x g for 30 
minutes, the synthesized AdoMet was purified from ATP by reversed phase HPLC using 
a semi-preparative Hypersil 5 C18 column (250 x 10 mm, 5 µm, Phenomenex).  The [U-
ribosyl-14C]-AdoMet was eluted under isocratic conditions of 98% 20 mM ammonium 
acetate (pH 6.0)/2% Methanol.  The [U-ribosyl-14C]-AdoMet fractions were immediately 
collected and acidified by addition of H2SO4 and lyophilized to dryness.  The 
concentration was determined by UV-spectroscopy, the purity of the [U-ribosyl-14C]-
AdoMet was verified by TLC, UV/Vis spectroscopy and HPLC against the authentic 
material. 
 
In vivo expression and purification of tRNATyr 
E. coli K12QueA/pTRC99B-Tyr was grown in LB/amp medium at 37 °C.  A glycerol 
stock was used to inoculate 3 mL of LB/amp medium and the culture was left to grow for 
12 hours, after which 1 mL was taken and used to inoculate 100 mL of LB/amp medium.  
The 100 mL cultures were grown for 12 hours at 37 ºC with shaking at 250 rpm, 5 mL 
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aliquots were taken from the 100 mL cultures and were used to inoculate 500 mL of 
LB/amp medium.  The cells in the 500 mL culture were grown for about 3 ½ hours until 
an OD600 of about 0.9 was reached at which point the over-expression of tRNATyr was 
induced by the addition of IPTG to a final concentration of 0.5 mM.  The cultures were 
allowed to grow for an additional 13 hours and were harvested by centrifugation at 5,000 
x g for 15 minutes and frozen with liquid nitrogen.  The cells were stored at -80 ºC until 
further use. Approximately 50 g of cells were obtained from 7 L of LB. 
 
The acid guanidium thiocyanate-phenol-chloroform method was used to lyse the cells 
and extract the ribonucleic acids (68).  Twenty grams of cells were suspended in 40 mL 
of 4 M guanidium thiocyanate, 0.5% N-lauroylsarcosine, 100 mM βME and 25 mM 
sodium citrate (pH 7.0).  The cells were lysed by stirring at 4 ºC for 1 hour followed by 
addition of 4 mL of 2 M sodium acetate (pH 4.0).  The mixture was stirred for an 
additional 5 minutes and 40 mL of water-saturated phenol was added.  After shaking for 
5 minutes, 8 mL of choloroform: isoamyl alcohol (49:1) were added and the solution 
shaken vigorously for 10s.  The aqueous phase was recovered after centrifugation at 800 
x g for 20 minutes and the RNA was precipitated with the addition of an equal volume of 
isopropanol followed by incubation at -20 ºC for 2 hours.  The precipitate was collected 
by centrifugation at 20,000 x g for 20 minutes and washed with 70% ethanol.  The 
enriched RNA was subjected to a second round of the acid guanidium thiocyanate-
phenol-chloroform extraction using a quarter of the original volumes to ensure complete 
removal of the proteins.  After washing the RNA pellet with 70% ethanol and 
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centrifuging, the pellet was dissolved in DEPC-treated water and an equal volume of 8 M 
LiCl was added.  The solution was placed at -20 ºC for 2 hours, followed by 
centrifugation at 20,000 x g for 20 minutes to remove the large RNAs.  The supernatant 
containing the tRNATyr was precipitated with isopropanol and washed with 70% ethanol 
as previously described.  The pellet was suspended in 3 mM sodium citrate pH 6.3.  The 
concentration of tRNATyr was estimated by UV-Vis spectroscopy ε260 = 861,000 L mol-
1cm-1.  Approximately 20% of the total RNA was determined to be tRNATyr by the tRNA 
synthetase activity assays and QueA assay. 
 
Purification of the tRNATyr 
Crude tRNA (50 mg) was loaded on a 12 mL column (1cm ID) of BND cellulose in 20 
mM NaOAc (pH 4.5), 10 mM MgCl2, and 0.5 M NaCl (69).  A 100 mL linear salt 
gradient 0.5 M to 1.0 M NaCl was applied followed by washing with 1 M NaCl until the 
absorbance reading was below 0.25.  A 40 mL ethanol gradient (0-20%) was applied for 
the elution of tRNATyr.  The volume of each fraction was 2 mL and the flow rate was 0.5 
mL/minute.  The presence of tRNATyr was assayed by the tRNA-tyrosine synthetase 
assay and fractions which contained tRNATyr were pooled and the tRNA was precipitated 
with isopropanol at 50% final concentration.  The tRNATyr was further purified by 
continuous elution PAGE using BioRad 491 Prep Cell with 7 M Urea, 12% acrylamide 
gel.  The tRNATyr was prepared in 50% formamide (v/v), 10 mM EDTA, 0.1% (w/v) 
xylene cyanol FF and 0.1% (w/v) bromophenol blue.  The gel was run at 300 V, and 3 
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mL fractions were collected at a flow rate of 1 mL/min.  The complete run took about 13 
hours.  To remove bound metal ions from the tRNATyr, it was washed with a 10 fold 
volume of 3 mM sodium citrate followed by precipitation with isopropanol and cooling at 
-20 ºC for 2 hours followed by centrifugation.  The pellet was resuspended in 3 mM 
sodium citrate (pH 6.3).  The concentration of tRNATyr was determined by the tyrosine-
synthetase assay and QueA assay and found to comprise greater than 70% of the isolated 
tRNA. 
 
In vitro transcription and purification of minihelix 17-mer 
An RNA 17-mer representing the E. coli tRNAAsn anticodon stem-loop 
(5’GCGGACUGUUAAUCCGC-3’) was synthesized in a reaction containing 40 mM 
Tris-HCl (pH 8.0), 20 mM MgCl2, 1 mM spermidine, 50 µg/mL BSA, 2.5 mM DTT, 
0.01% Triton X-100, 80 mg/mL polyethylene glycol, 0.5 µM of top and bottom DNA, 4 
mM NTPs and 64 µg/mL T7-polymerase.  The reaction was incubated at 37 ºC for 6 
hours at which point the reaction was stopped by heating at 95 ºC for 3 minutes, followed 
by centrifugation at 20,000 x g for 10 minutes.  The 17-mer was precipitated by an equal 
amount of isopropanol and cooling at -80 ºC for 2 hours.  The cold solution was 
centrifuged at 20,000 x g at 4 °C 30 minutes.  The pellet was washed with cold 70% 
ethanol and placed at -20 ºC overnight.  The solution was centrifuged at 20,000 x g for 30 
minutes and the pellet was resuspended in 400 µL of 3 mM citrate (pH 6.3). 
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The crude RNA was treated with RNase-free DNase (40 Units/mL of the in vitro 
transcription) in 40 mM Tris-HCl (pH 8.0), 10 mM NaCl, 6 mM MgCl2 and 10 mM 
CaCl2 for 30 minutes.  The RNA oligomer was purified by continuous elution PAGE 
using the BioRad 491 Prep Cell with a 7 M urea, 20% acrylamide gel in the following 
manner:  10 mg of RNA in 80% formamide (v/v), 10 mM EDTA, 0.1% (w/v) xylene 
cyanol FF, and 0.1% (w/v) bromophenol blue were loaded onto the gel and the sample 
was electrophoresed at 200 V until the bromophenol blue was eluted, at which point 
fraction collection began.  Fractions (5 mL) were collected until xylene cyanol FF eluted.  
The elution of the 17-mer was monitored on Urea/PAGE gels.  The fractions containing 
17-mer were pooled and concentrated by lyophilizing.  The concentration of the RNA 
was determined by UV/Vis spectroscopy with ε260 = 162,000 L mol-1 cm-1 and MW= 
5442.4 Da.  
 
Insertion of preQ1 into the minihelix RNA 
The preQ1 base was inserted into the 17-mer in an E. coli TGT-catalyzed reaction.  A 75 
µg aliquot of TGT was added to a 1 mL solution containing 20 mM HEPES (pH 7.5), 10 
mM MgCl2, 50 mM KCl, 2 mM DTT, 50 µM 17-mer and 300 µM preQ1.  After 3 hours 
at 37 ºC, the reaction was terminated by the addition of 0.1 volumes of 2 M NaOAc (pH 
4.0) followed by one volume of water-saturated-phenol and 0.2 volumes of 
chloroform:isoamyl alcohol (49:1).  After vortexing for 20s, the solution was centrifuged 
in a swinging bucket rotor at 700 x g for 20 minutes.  The aqueous phase was recovered 
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and applied directly to a Quick-Sep column containing 2 mL of Sephadex G-25.  The 
sample was centrifuged at 700 x g in a swinging bucket rotor for 1½ min to separate the 
unreacted preQ1 from the 17-mer.  The 17-mer in the eluate was precipitated by an equal 
amount of isopropanol and cooling at -20 ºC overnight.  The solution was centrifuged at 
20,000 x g for 20 minutes and the RNA pellet was washed with 70% cold ethanol and 
centrifuged again at 20,000 x g at 4 ºC. The 17-mer was resuspended in 3 mM citrate (pH 
6.3) and stored at -80 ºC. 
 
Determination of stereospecific abstraction of hydrogen by QueA 
The conversion of preQ1 from either the 17-mer or tRNATyr was carried out under the 
conditions of: 100 mM Gly-gly (pH 8.7), 100 mM EDTA (pH 8.7), 100 mM KCl, 50 µM 
tRNA, 25 µM QueA and 1.0 mM of either (5’S)-[5’-2H]-AdoMet or (5’R)-[5’-2H]-
AdoMet.  The reaction was left to run for 1 hour and terminated by heating for 3 minutes 
at 95 ºC.  The mixture was centrifuged at 20,000 x g in order to remove precipitated 
protein, followed by separation of RNA from other reaction components by use of a spin 
column with 500 µl G-25 sephadex.  This process was performed twice and the collected 
RNA was precipitated out by adding 0.1 volumes of 2 M NaOAc (pH 4.0) and one 
volume of isopropanol and cooling at -20 ºC for 2 hours.  The RNA was resuspended in 
water to a final concentration of 1 µg/mL.  The RNA digestion was carried out as 
previously described (63).  The RNA was denatured by heating at 100 ºC and rapidly 
chilled in ice-water slush.  One tenth volume of NH4OAc 0.1 M (pH 5.3), 5 µg of 
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Nuclease P1 was added for 1 mg of RNA and the digestion was incubated at 42 ºC for 4 
hours.  This was followed by adding 0.1 volumes of freshly made 1 M NH4HCO3 (pH 
7.8) and 0.05 U of phosphodiesterase the digestion was carried out for another 4 hours at 
37 ºC.  Lastly 20 Units of alkaline phosphatase were added and the dephosphorylation 
was carried out for 2 hours at 37 ºC.   
 
The oQ was purified on the HPLC by use of an analytical Gemini column (250 x 4.6 mm, 
5 micron, Phenomenex), under gradient conditions of 100% 25 mM NH4OAc (pH 6.0) to 
90% 25 mM NH4OAc/10% Acetonitrile at a flow rate of 1 mL/min over 30 min.  The oQ 
was collected, lyophilized and made up in 10 mM NH4OAc (pH 6.0)/50% methanol 
followed by direct infusion analysis using a Thermo LCQ ion trap mass spectrometer.  
The analysis was carried out in the positive mode.  Proton NMR of the streospecifically 
labeled AdoMet used in this analysis was carried out under acidic conditions with a pH of 
approximately 3.0 in D2SO4. 
 
 
 
 
57 
 
3. RESULTS 
 
3.1 MjTgtA2 
Identification, cloning, and purification of MjTgtA2  
Using the gene clustering tool of the SEED database, the gene families that physically 
clustered with tgtA, which encodes the archael TGT and encoded proteins with RNA-
binding domains were identified as possible candidates for the enzyme involved in the 
final transformation of preQ0-tRNA to G+-tRNA (Figure 16A).  The tgtA2 family was 
identified as a possible candidate, as members of this family cluster with tgtA genes in 
phylogenetically distant archaea (Figure 16B). These genes had been previously 
annotated as encoding TGT enzymes in most archaeal genomes because the 
corresponding proteins present around 18% sequence identity with the canonical TGT 
[the identity score was obtained from comparing the M. janaschii TGT (MJ0436) and 
TgtA2 (MJ1022)].  Detailed analysis of the sequence alignments of the TGT and TgtA2 
families revealed that, while the C2 and PUA domains were well conserved between the 
two protein families, the N-terminal and C1 domains were not (70).  The major 
differences in those two domains are the following: (a) the N-terminal domain in the 
TgtA2 family is smaller than its counterpart in the TGT family by 70-130 N-terminal 
residues, (b) active site and known catalytic residues in the N-terminal domain of TGT 
are not conserved in TgtA2, (c) the C1 domain in TgtA2 is much larger than its 
counterpart in TGT (200 residues in TgtA2, but only 40 in TGT) and (d) the C1 domain 
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of TgtA2 contains a TgtA2-specific motif PC-X3-KPY-X2-S-X2-H (Figure 16C) not 
found in TGT (70).  The combination of the clustering evidence and the presence of a 
PUA domain suggested that the tgtA2 gene family encoded an enzyme catalyzing one or 
more steps in the conversion of preQ0-tRNA to G+- tRNA and was not a canonical TGT. 
 
The mj1022 gene corresponding to tgtA2 gene in M. jannaschii was initially cloned from 
genomic DNA via PCR and inserted into a pET32Xa/LIC vector to enable expression of 
the recombinant protein as an N-terminal His6-Trx-fusion protein.  The over-expression 
of protein in E. coli BL21(DE3) was associated with low levels of recombinant protein 
and production of truncated proteins.  Sequence analysis of the mj1022 gene revealed that 
it was highly A-T rich and contained numerous codons for lysine and arginine that are 
rarely used in E. coli.  The expression profile was only marginally improved by 
expression in Rosetta2 ™ cells, which are engineered to over-express a number of 
specific tRNAs to compensate for the presence of rarely used codons in E. coli.  In order 
to improve protein expression, a codon-optimized synthetic gene was prepared for 
expression in E. coli, and cloned via PCR into pET32Xa/LIC and pET30Xa/LIC 
expression vectors harboring N- and C-terminal His6 fusion tags.   
 
Expression from pVCIII-28 and pVCIV-42, which encode the N- and C-terminal His6 
fusions, respectively, in E. coli BL21(DE3) was robust, and provided ~25 mg of 
recombinant protein per liter of culture.  However, purified protein obtained after Ni2+-
NTA agarose affinity chromatography was typically contaminated with one or more other 
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polypeptides (Figure 17).  In the case of the His6-Trx-fusion protein, several large bands 
~15 KDa less than the fusion were observed, as well as a small band that was ~15 KDa, 
while in the samples of C-terminal His6 fusion protein a single additional band ~7 KDa 
smaller than the fusion was observed.  When these samples were kept at temperatures 
above freezing (4 °C to 25 °C) over a period of days to weeks, all of the fusion protein 
converted to the smaller bands.  Various protease inhibitors that were tested did not 
prevent or influence the cleavage reaction, suggesting that the protein was undergoing 
self-cleavage.  The protein was prone to precipitation in different forms either as a fusion 
or the cleaved product and required at least 0.5 M NaCl to remain in solution. 
 
Determination of self-cleavage sites in N- and C-terminal fusions of MjTgtA2 
To allow the N- and C-terminal recombinant fusion proteins to self-cleave, the Trx-His6- 
MjTgtA2 and MjTgtA2-His6 fusion constructs were incubated at 4 °C for up to 4 weeks 
and analyzed by Edman degradation.  N-terminal sequencing revealed that while 
cleavage occurred in 2 specific regions, one within the fusion domain (Figure 18B) and a 
second ~75 residues into the N-terminal domain of the native protein (Figure 18C), N-
terminal heterogeneity was observed due to multiple cleavage sites within each region 
(Table 1). 
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Size exclusion chromatography 
To evaluate the native molecular masses of His6-Trx-MjTgtA2 and cleaved MjTgtA2, 
analytical size exclusion chromatography was carried out (Figure 19).  A standard curve 
was generated using carbonic anhydrase (29KDa), BSA (66 KDa), alcohol dehydro-
genase (150 KDa), β-amylase (200 KDa), apoferritin (443 KDa) and thyroglobulin (669 
KDa).  The His6-Trx-MjTgtA2 eluted with a calculated KD of 0.592.  For cleaved 
MjTgtA2, the KD was 0.620.  These were consistent with molecular weights of 154 kDa 
and 122 kDa, and both masses were consistent with the formation of a dimer.  
 
preQ0-tRNASer substrate preparation 
Continuous PAGE was used to purify the tRNASer transcript (Figure 20) which was 
composed of mainly two bands.  The purified larger band was used for the subsequent 
preQ0 incorporation reaction catalyzed by MjTGT.  The lower band was assumed to be 
the n-1 transcript product.  The final product was pure as judged by PAGE (Figure 20).  
In order to determine the amount of tRNASer that contained preQ0, MjTGT was initially 
used to incorporate [8-14C]guanine into tRNASer.  The [8-14C]guanine previously 
incorporated in tRNASer was then replaced by preQ0 in reaction catalyzed by MjTGT , and 
essentially no radioactivity was detected after the preQ0 incorporation giving greater than 
95 % preQ0-tRNASer.  
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Glutaminase assays 
The transformation of preQ0 to archaeosine suggested that the reaction could be catalyzed 
by an amidotransferase.  Glutaminase activity was determined in the presence and 
absence of ATP and preQ0-tRNASer.  To probe for potential glutaminase activity that is a 
characteristic trait of most amidotransferase enzymes, a coupled assay of MjTgtA2 with 
glutamate dehydrogenase was used, and the reaction was followed by monitoring 
NADPH production at 340 nm (Figure 21).  [U-14C]-L-glutamate formation was also 
monitored directly by using [U-14C]-L-glutamine.  Glutamate formation in the MjTgtA2 
assays, as deduced from glutamate dehydrogenase activity or from the direct production 
of [U-14C]-L-glutamate, was dependent on MjTgtA2 (Figure 21 and 22) and did not 
require ATP.  Glutaminase activity was also determined in the presence of buffers other 
than phosphate including, citrate, succinate, acetate, and HEPES.  Glutaminase activity 
was observed over a broad pH range (4.0 – 8.0) as shown in Figure 24, but was greatest 
in HEPES buffer at pH 7.0 (Figure 25).  Optimal glutaminase activity occurred at ~40 ˚C 
and dropped off significantly above 45 ˚C (Figure 23).  Based on radiochemical assays 
for glutaminase activity, specific activities of 7.7, 11.4, and 16.3 µM/min/mg were 
calculated for the self-cleaved protein, the full fusion protein, and the C-terminal tagged 
protein, respectively.  
In vitro amidotransferase activity of MjTgtA2 
To determine if the glutaminase activity of MjTgtA2 was associated with an 
amidotransferase activity and the formation of archaeosine, the ability of MjTgtA2 to 
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catalyze archaeosine formation under various conditions was investigated.  LC analysis 
of the tRNA hydrolysates obtained from MjTgtA2 reactions carried out in the presence or 
absence of ATP revealed a new peak with a retention time 17.9 min and a chromophore 
(Figure 27A and 27C) that were distinct from that of preQ0 (17.1 min, Figure 27A and 
B), but consistent with that of archaeosine (20).  Subsequent LC-MS analysis of the 
MjTgtA2-catalyzed reaction tRNA hydrolysates provided a parent ion (MH+ 325.1 m/z) 
shown in Figure 28A consistent with archaeosine, as well as a significant daughter ion 
(BH2+ 193 m/z) consistent with the archaeosine nucleobase.  Archaeosine formation was 
also observed when asparagine and NH4Cl were used in place of glutamine.  Using [3H]-
asparagine, a specific activity of 3.23 µM/min/mg was calculated for asparaginase 
activity with the fusion form of the enzyme in the absence of preQ0-tRNA (Figure 26).  
Formation of G+ was also determined at various pH values; however unlike glutaminase 
activity that was found to occur at acidic pH values, G+ formation was only observed at 
pH 7 and above (Table 2).   
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3.2 NADPH 7-cyano-7-deazaguanine oxidoreductase 
Expression and purification of QueF proteins 
Wild type QueF, C55A and E78A mutants were all expressed as fusion proteins from 
pET30Xa-ykvm, pET30Xa-ykvm-E78A and pET30Xa-ykvm-C55A in E. coli 
BL21(DE3) and purified by Ni2+-NTA agarose chromatography.  The SDS-PAGE gel 
showing QueF purification is shown in Figure 29.  The proteins were all cleaved using 
Factor Xa and the native proteins were obtained.  The cleaved fusion protein was 
removed by a second round of purification on Ni2+-NTA agarose, where the cleaved tag 
remained bound to the resin and the native protein was eluted in the absence of 
imidazole.  The QueF proteins were obtained to over 95% homogeneity as shown in 
Figure 30.   
 
Metal analysis 
The effect of divalent metals on the activity of QueF was investigated.  In order to 
circumvent any potential time dependence on metal binding, the protein was preincubated 
with the metal for at least 5 minutes before the reaction was initiated by the addition of 
preQ0.  The activity of the native proteins was determined in the presence of Mn2+, Cu2+, 
Ca2+, Zn2+ and Mg2+ against a control of native QueF with EDTA
 
(Figure 31).  The 
protein activity was observed to increase in the presence of divalent metals, however the 
presence of EDTA was observed to result in a decrease in activity (Figure 31).  At 
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concentrations >1 mM for the Mn2+ and Ca2+ an inhibitory effect was observed, however 
this was not observed in the presence of Mg2+.  Increased protein activity was only 
observed at low concentrations for Zn2+ and Cu2+ (10 µM), however at concentrations 
>10 µM reduced activity was observed.  Only Ca2+, Mg2+ and Mn2+ were used to further 
determine their effect of QueF activity (Figure 32), all three metals were found to 
increase the activity of the apparent apoprotein.   
 
The effect of KCl on the activity of both the native and apparent apoprotein was 
investigated, in the absence and presence of MnCl2.  The activities of both the native and 
apparent apoprotein were diminished in the presence of 100 mM KCl.  However in the 
presence of MnCl2, the activity of native QueF was found to be the same at both 50 mM 
and 10 mM KCl, while the activity of the apoprotein was found to be greatest in the 
presence of MnCl2 at 50 mM KCl.  The effect of KCl is shown in Figure 33. 
 
pH optima determination 
The effect of pH on the activity of QueF was determined in MES (pH 5.5 - 6.67), Tris-
HCl (pH 6.8 -7.9), and potassium phosphate buffer (pH of 5.8 - 8.0).  The optimal pH for 
QueF activity was determined to be 6.5.  All subsequent analyses were determined in the 
presence of potassium phosphate pH 6.5 at 30 °C.  The pH profiles are shown in Figure 
34. 
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Size exclusion chromatography of QueF 
The role of KCl, divalent metals, and the substrate preQ0 in the oligomeric structure of 
QueF was evaluated by analytical size exclusion chromatography using a BioSep-Sec-
4000 column (Phenomenex) with a mobile phase of 25 mM phosphate (pH 7.2), 25 mM 
KCl, at 1 ml/min.  In experiments with preQ0 the enzyme and substrate were incubated 
together for at least 10 minutes before the sample was injected for analysis, with the 
preQ0 concentration present at two times the concentration of QueF.   
 
The elution behavior of QueF in the absence of preQ0 and in the presence of a low salt 
concentration (25 mM KCl) exhibited a broad, asymmetric peak with a retention time of 
8.57 minutes (Figure 35A), corresponding to a MW of 200.7 kDa.  The retention time of 
QueF in the presence of preQ0 (i.e QueF-*PreQ0) shifted to 8.33 minutes (Figure 36A), 
and while still exhibiting asymmetry the peak was sharper and narrower than in the 
absence of preQ0.  A smaller poorly defined peak was also observed to at an elution time 
of 10.4 minutes, corresponding to a MW of 15.8 kDa close to the subunit MW of QueF 
(19.4 kDa).  Analysis of the absorption spectra for both peaks revealed the presence of a 
distinct absorption at 376 nm (Figure 36 B and C) previously ascribed to the putative 
thioimide intermediate.  
 
The effect of KCl on the quaternary structure of QueF was investigated by observing the 
elution behavior of the enzyme under different salt concentrations.  The QueF protein 
sample was initially incubated for 3 hours in the presence of 0.5 M KCl and 10 mM 
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EDTA before analysis of the sample.  At 0.5 M KCl the retention time of the apparent 
multimeric state of the protein eluted later (8.78 minutes, Figure 35B) compared to 8.57 
minutes (Figure 35A) observed in the absence of salt.  Additionally a peak consistent 
with a monomer was observed to elute with a retention time of 10.4 minutes (Figure 
35B).  The presence of an excess of either of the divalent metals Mg2+ or Mn2+ appeared 
to have no effect on quaternary structure as the retention times (data not shown) of QueF 
in the presence of the these ions were identical to that of QueF alone. 
 
QueF Crystal structure 
Crystal structures of QueF were determined in collaboration with Dr. Manal A. Swairjo 
(Western University of Medicine).  Crystal structures of QueF at 2.5 Å and 2.25 Å 
resolution where solved for the covalent binary complex of QueF with preQ0 trapped in 
the thioimide intermediate state, and of a non-covalent ternary complex with preQ0 and a 
cofactor surrogate, respectively.  The overall enzyme structure in both reveals an 
asymmetric tunnel-fold homodecamer of two head-to-head facing pentameric subunits 
possessing the characteristic architecture of unimodular pterin and purine binding 
enzymes (Figure 37).  Each of the ten active sites in the QueF homodecamer lie at the 
interface between three subunits, two from one beta barrel and one from the opposite beta 
barrel.  The active site is comprised of the substrate and cofactor binding pockets.  The 
preQ0 binding pocket is defined by a cleft between the two subunits from the same beta 
barrel.  PreQ0 forms hydrogen bonds via its N1 and N2 atoms with the invariant Glu97 
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side chain, and via its N9 atom with the side chain of Glu79 (the first residue in the 
conserved QueF motif).  The substrate binding pocket is also lined with hydrophobic 
residues that make Van der Waals interactions with preQ0.  PreQ0 is bound in eight of ten 
active sites, and forms a thioimide covalent linkage with the conserved catalytic residue 
Cys55, consistent with previous biochemical evidence.  The pentameric substructure of 
QueF is shown in Figure 38; the subunit without the thioimide is present in a different 
conformation when compared to the subunits with thioimide.  Figure 39 shows the first 
structural evidence of the thioimide formed in the QueF active site.  The crystal structure 
of the QueF-PreQ0 thioimide intermediate complex clearly shows that the Cys55 sulfur 
atom forms a 1.87 Å covalent bond with the preQ0 nitrile carbon atom.  The 
conformational changes seen in the active site upon thioimide formation are rotations in 
the side chains of Cys55 and Asp62.   
 
Glucosamine originating from dextran sulfate, which was included as an additive in the 
crystallization buffer, is observed in the adjacent active site to the preQ0 binding site 
(Figure 40).  This ligand apparently acts a as surrogate of the enzyme cofactor NADPH 
and occupy the putative NADPH site predicted previously using modeling tools.  The 
cofactor pocket is at the interface between three subunits and involves residues from all 
three.  The QueF motifs from two subunits contribute side chains to the cofactor binding 
site.  
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QueF fluorescence assays  
The tryptophan residue` has been used extensively in the determination of ligand and 
protein interactions.  Since QueF has a single tryptophan residue at position 119, the 
fluorescence of QueF in the presence and absence of preQ0 was measured in order to 
study QueF and preQ0 interactions.  When tryptophan was excited at 295 nm, QueF was 
found to have an emission maximum at 334 nm while the emission maximum of 
quenched QueF-PreQ0 complex was observed to shift to 328 nm (Figure 41A).  The 
optimal emission for NADPH was also determined under the reaction conditions to be at 
465 nm (Figure 41B) when excited at 340 nm. 
 
Transient state kinetics data analysis 
For data analysis with Dynafit, a model for the reaction taking place was put forth for 
different reactions in order for the program to calculate the rate constants for the various 
steps in the QueF-catalyzed reaction of reduction preQ0 to preQ1. 
 
The fitting function (model equation) for each individual data set is  
S(t) = S0 + ∑ni=1 ri ci(t)  
where  
S(t)  the experimental signal observed at time t  
S0  offset on the signal axis (a property of the instrument)  
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n  number of unique molecular species participating in the reaction mechanism  
ci(t)  the concentration of the ith species at time t  
ri  the molar response coefficient of the ith species  
The molecular species participating in the mechanism are defined for each of the various 
reactions.  The concentrations of these molecular species at time t are computed from 
their initial concentrations (at time zero, t = 0) by solving an initial-value problem 
defined by a system of simultaneous first-order Ordinary Differential Equations (ODEs) 
listed for each of the reactions below.  
 
Fluorescence measurements of preQ0 binding to QueF C55A 
 
In order to investigate the binding of preQ0 to QueF in the absence of thioimide 
formation the kinetics of preQ0 binding were first determined with the C55A mutant of 
QueF, which is incapable of reacting to form the thioimide.  Binding was monitored by 
measuring the change in the intrinsic tryptophan fluorescence under pre-steady state 
conditions.  The proposed model for binding of QueF (C55A) and preQ0: 
 
                         
QueF    +      PreQ0                          QueF.PreQ0
kas
kds
 
 
Ordinary Differential Equations  
Where S = PreQ0 and E= QueF 
d[E]/dt = - kas[E][S] + kds[ES] 
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d[S]/dt = - kas[E][S] + kds[ES] 
d[ES]/dt = + kas[E][S] - kds[ES] 
 
When binding was initially investigated at 30 ˚C, the normal assay temperature for QueF, 
the binding was too fast to be measured accurately in the millisecond time regime, so the 
temperature was lowered to 20 ˚C. Under these conditions binding was clearly observable 
and the data were nicely fit with a single exponential, the association constant from 
global analysis of the data (Figure 42A);  was calculated to be 1.06 ± 0.31 µM-1s-1, with a 
dissociation constant of 1.35 ± 0.26 s-1.  
 
Fluorescence measurements of preQ0 binding to wild type QueF 
 
In order to investigate preQ0 binding and thioimide formation, fluorescence measure-
ments were conducted on wild-type QueF.  Previous experiments demonstrated that the 
thioimide intermediate was stable over several hours (71), and therefore the breakdown 
of the covalent adduct was assumed to be negligible in evaluating kinetic data under pre-
steady state conditions.  The proposed model for preQ0 binding and thioimide formation 
in wild type QueF thus was the following: 
 
                         
QueF    +      PreQ0                          QueF.PreQ0       
       
       QueF.PreQ0                                QueF-*PreQ0
kas
kds
kr
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Ordinary Differential Equations  
Where E = QueF, S = PreQ0, E-S = QueF-*PreQ0 (QueF with thioimide) 
d[E]/dt  = -kas[E][S] + kds[E.S]  
d[S]/dt  = -kas[E][S] + kds[E.S]  
d[E.S]/dt  = +kas[E][S] - kds[E.S] - kr[E.S]  
d[E-S]/dt  = + kr[E.S] 
Experiments were again carried out at 20 ˚C, but in this case the data was biphasic and 
was only adequately fit by a double exponential.  The association constant from global 
analysis of the data was calculated to be 1.32 ± 0.26 µM-1s-1, identical within 
experimental error to the value calculated with the C55A mutant, while the dissociation 
constant was found to be 7.95 ± 1.52 s-1, roughly 8-fold larger than in the mutant.  The 
rate of thioimide formation was found to be 1.30 ± 0.05 s-1.  
 
Absorbance measurements of thioimide formation in QueF under pre-steady state 
conditions 
The kinetics of thioimide formation were also investigated by directly observing the 
appearance of the thioimide absorbance band at 370 nm.  When the data were fit to a two-
step mechanism comprising preQ0 binding followed by thioimide formation, identical to 
that utilized in the fluorescence experience, the residuals were clearly non-random 
(Figure 44C).  In this case the data was better fit by a mechanism incorporating another 
step prior to the formation of the thioimide, such as an isomerization step or a shift in the 
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equilibrium of a heterogeneous population of QueF to give the reactive form of the 
protein upon mixing with the preQ0.  The proposed model for reaction of QueF with 
preQ0 is shown below: 
                     
F       +      F                                 QueF               
QueF   +   PreQ0                          QueF.PreQ0                
       QueF.PreQ0                           QueF-*PreQ0
kef
kfe
kas
kds
kr
 
 
Ordinary Differential Equations  
Where F = pentamer, E = QueF= decamer 
d[F]/dt  =  - kef[F][F] - kef[F][F] + kfe[E] + kfe[E]  
d[E]/dt  =  + kef[F][F] - kfe[E] - kas[E][S] + kds[ES]  
d[S]/dt  =  - kas[E][S] + kds[ES]  
d[ES]/dt  =  + kas[E][S] - kds[ES] - kr[ES]  
d[E-P]/dt  =  + kr[ES]  
 
Using this model global analysis of the data (Figure 44A and B) provided a rate for 
thioimide formation of 2.55 ± 0.014 s-1 at 30 ˚C, in close agreement to the value calcula-
ted above from the fluorescence experiments carried out at 20 ˚C.   
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Fluorescence measurements of NADPH binding to the E78A mutant QueF-*PreQ0 
under transient state kinetics 
Proposed model for NADPH binding to E78A QueF-*PreQ0 : 
                 
QueF-*PreQ0   +   NADPH                     QueF-*PreQ0.NADPH    
   
       QueF-*PreQ0.NADPH                       F-*PreQ0.NADPH
kas
kds
k1
k
-1
 
Ordinary Differential Equations  
where E-S = QueF-*PreQ0, and F-*PreQ0 is a different state of the protein possibly after 
isomerization  
d[E-S]/dt  =  - kas[E-S][NADPH] + kds[E-S.NADPH]  
d[NADPH]/dt  =  - kas[E-S][NADPH] + kds[E-S.NADPH]  
d[E-S.NADPH]/dt =  + kas[E-S][NADPH] - kds[E-S.NADPH]  
-k1[E-S.NADPH] + k-1[FS.NADPH]  
d[FS.NADPH]/dt  =  + k1[E-S.NADPH] - k-1[FS.NADPH]  
 
The association constant from the Dynafit and KaleidaGraph analysis was found to be 0.2 
± 0.01 µM-1 s-1 and the dissociation constant was found to be 0.24 ± 0.06 s-1 , the 
isomerization constants of the protein after binding of NADPH were calculated to be k1 = 
1.18 ± 0.04 s-1 and k
-1 = 0.12 ± 0.02 s-1at 20 oC.  The global analysis (Figure 45 C) and an 
example of residuals for the fit are shown in Figure 45 D, while the biphasic nature of the 
data is clearly shown by the Kaleidagraph fits for single and double exponential decay in 
Figure 45 A and B. 
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Fluorescence measurements of NADPH binding and thioimide reduction under 
single turnover conditions 
 
The proposed model for NADPH binding and thioimide reduction in wild type QueF-
*PreQ0 under single turnover conditions is shown below.  NADPH fluorescence was 
monitored. 
                
QueF-*PreQ0    +   NADPH                     QueF-*PreQ0.NADPH            
        QueF-*PreQ0.NADPH                     QueF=*PreQ0.NADP+
kas
kds
kr
 
 
Ordinary Differential Equations  
d[E-S]/dt = - kas[E-S][NADPH] + kds[E-S.NADPH] 
 
d[NADPH]/dt = - kas[E-S][NADPH] + kds[E-S.NADPH]  
 
d[E-S.NADPH]/dt = + kas[E-S][NADPH] - kds[E-S.NADPH] - kr[E-S.NADPH]  
 
d[E=S.NADP+]/dt = + kr[E-S.NADPH]  
 
The association constant (kas) from the Dynafit and KaleidaGraph analysis was found to 
be 0.06 ± 0.0007 µM s-1 and the dissociation constant (kds) was found to be 0.2 ± 0.03 s-1 
while the rate of reduction (kr) was calculated to be 0.12 ± 0.01 s-1at 20 oC.  The global 
analysis and an example of residuals for the fit are shown in Figure 46A and B.   
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Absorbance measurements of thioimide reduction monitored at 390 nm 
Thioimide reduction was also determined directly by monitoring the thioimide 
absorbance.  In order to avoid the overlap in the NADPH and thioimide absorptions 
(Figure 47), the reaction was monitored at 390 nm.  The proposed model for NADPH 
binding and thioimide reduction in wild type QueF-*PreQ0 under single turnover 
conditions is shown below.   
 
                    
QueF-*PreQ0    +   NADPH                     QueF-*PreQ0.NADPH            
        QueF-*PreQ0.NADPH                     QueF=*PreQ0.NADP+
kas
kds
kr
 
 
Ordinary Differential Equations  
d[E-S]/dt  =  - kas[E-S][NADPH] + kds[E-S.NADPH]  
d[NADPH]/dt  =  - kas[E-S][NADPH] + kds[E-S.NADPH]  
d[E-S.NADPH]/dt  =  + kas[E-S][NADPH] - kds[E-S.NADPH] - kr[E-S.NADPH]  
d[E-S.*NADP]/dt  =  + kr[E-S.NADPH]  
The kas (0.06 µM s-1) and kds (0.2 s-1) used in this analysis were determined in the 
experiment monitoring NADPH fluorescence.  The rate of reduction (kr) was calculated 
to be 0.24 ± 0.0007 s-1at 30 oC the global analysis and an example of residuals for the fit 
are shown in Figure 48.   
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Absorbance measurements of thioimide decomposition 
 
Thioimide decomposition was monitored at 370 nm and data was collected on the Carey 
100 spectrophotometer.  The proposed mechanism is shown below; 
 
                             
QueF-*PreQ0                      QueF  +  PreQ0kr
 
 
Ordinary Differential Equations  
Where A = QueF-*PreQ0, E = QueF and S = PreQ0 
d[A]/dt  =  - kr[A]  
d[E]/dt  =  + kr[A]  
d[S]/dt  =  + kr[A]  
 
The rate of thioimide decomposition (kr) was calculated to be 4.81 ± 0.02 E-6 s-1at 30 oC 
the fitted data is shown in Figure 49. 
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3.3 S-Adenosylribosylmethionine:tRNA ribosyl transferase isomerase 
Stereospecific abstraction of the C5’ proton by QueA 
To investigate if the proton abstraction by QueA was stereospecific, stereospecifically 
labeled deuterium AdoMet was used.  PreQ1-tRNA that had been converted to oQ-tRNA 
was digested as previously described (63).  The proton NMR of the AdoMet used in the 
determination of stereospecific abstraction of the C5’ proton by QueA is shown in Figure 
53.  The proR proton is at the chemical shift of δ 4.05 in the unlabeled AdoMet while the 
proS proton is at the chemical shift of δ 3.919.  
 
Chromatograms showing the products of these digestions are shown in Figure 51, preQ1 
had a retention time of 17 minutes while oQ had a retention time of 22.5 minutes.  The 
oQ was collected from HPLC purification, oQ samples generated from 5’S-[5-D]-
AdoMet, 5’ R-[5-D]-AdoMet, and unlabeled AdoMet were all lyophilized and analyzed 
by mass spectrometry.  The results of these analyses are shown in Figure 52.  The data 
obtained indicate that QueA removes the 5’S proton of AdoMet.   
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4. DISCUSSION 
4.1 Archaeosine synthase  
Archaeosine is a modified nucleoside that has been found in most archaeal tRNAs 
analyzed to date.  However, until recently its biosynthesis was poorly characterized.  
Early biosynthesis studies on queuosine and structurally related metabolites led to the 
proposal that GTP was a metabolic precursor to archaeosine (37).  Even though TGT, the 
enzyme that catalyzes the insertion of preQ0 into tRNA was identified and characterized a 
decade ago (55, 72), candidate(s) for the transformation of preQ0-tRNA to archaeosine-
tRNA were yet to be identified and characterized.  The goal of this work was to test the 
hypothesis that the TgtA2 enzyme catalyzes the formation of archaeosine from preQ0 in 
tRNA. 
 
Comparative genomic analysis and in vivo studies were conducted to determine the 
participation of M. jannaschii TgtA2 (MjTgtA2) in archaeosine biosynthesis.  H. volcanii 
was chosen to investigate the in vivo function of tgtA2.  A ∆tgtA2 mutant was constructed 
in H. volcanii and LC-MS analysis on the tRNA hydrolysates indicated that no 
archaeosine was present in the mutant strain, suggesting that the tgtA2 gene encoded a 
protein involved in the biosynthesis of archaeosine.  To test this hypothesis, the tgtA2 
gene from M. jannaschii was cloned and the encoded protein, MjTgtA2, was expressed 
and purified. 
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The expression and purification of MjTgtA2 proved to be challenging as initial attempts 
to express from its native gene resulted in low levels of expression as well as truncated 
protein.  A codon-optimized gene was constructed in order to improve expression; 
however truncated protein was still obtained.  Slowing down transcription by lowering 
expression temperature as well as lowering the final IPTG concentration did not improve 
the protein expression.  MjTgtA2 was cloned in several vectors in order to improve both 
formation of full length protein as well as formation of soluble functional protein, but 
only the expression of soluble protein was improved.  In order to determine if the protein 
was being truncated due to the activity of proteases from E. coli, a protease inhibitor 
cocktail as well as EDTA were added during protein purification, but truncated protein 
was still obtained.  Expression of MjTgtA2 as a C-terminally tagged protein resulted in 
purification of full length protein.  This suggested that the truncated protein obtained 
during the purification was not due to protease activity from endogenous E. coli proteins 
but most likely due to a characteristic of MjTgtA2.  If the proteolysis observed was due to 
E. coli proteases the C-terminally tagged protein would have shown the same degree of 
cleavage observed in the N-terminally tagged protein.  Due to observed loss in activity of 
MjTgtA2 when stored at low temperatures (e.g - 20 °C), the protein was stored at 4 °C.  
However, SDS-PAGE analysis of the C-terminal His6- MjTgtA2 indicated the presence 
of a lower protein band that was absent when the protein was initially purified (Figure 
18).  SDS-PAGE analysis of the Trx-His6- MjTgtA2 also revealed that after incubation of 
the protein for several weeks at 4 °C all the protein was truncated to fragments of lower 
molecular weight (Figure 18).   
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Together, these results suggested that the protein was undergoing self cleavage.  Edman 
degradation was used to determine the N-terminal sequences of the bands.  The 
sequencing results indicated that proteolysis occurred in two regions in the protein, but 
did not appear to be highly specific.  Close analysis of the data obtained after sequencing 
did not reveal any particular sequence characteristics that might be required for self 
cleavage to take place.  It was interesting to note that the self cleavage in the protein 
appeared to occur quite readily during the purification in all the N-terminally tagged 
proteins, but when the recombinant protein was left to incubate at 4 °C the cleavage of 
the protein was very slow.  In order to determine if the choice of purification resin (Ni2+-
NTA agarose) was somehow catalyzing the cleavage reaction, the Trx-His6- MjTgtA2 
was incubated with several divalent metals (data not shown) and the proteins were 
monitored for several weeks.  However, no apparent increase in cleavage of the protein 
was noted when the samples incubated with divalent metals were compared to the sample 
with no additional divalent metal, suggesting that the Ni2+ or divalent metals did not 
influence the rate of cleavage.  The significance of self cleavage that was observed in the 
heterologously expressed protein remains unclear. It was also not clear whether self 
cleavage would occur when the protein is expressed in its native environment.   
 
Analytical gel filtration analysis of full length and purified self cleaved protein revealed 
that MjTgtA2 formed dimers in solution.  Interestingly TGT has also been observed to 
form dimers (73). 
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Analysis of the possible chemistry in the transformation of a nitrile group to a 
formamidine group in tRNA resulted in a proposal of two possible routes (Figure 54).  
The first involved nitrile hydratase activity, to yield 7-amido-7-deazaguanosine, which 
could then be converted to archaeosine in a canonical amidotransferase catalyzed 
reaction.  This route had precedence in a known nitrile hydratase from Streptomyces that 
hydrolyzes the nitrile of the structurally similar toyocamycin (7-cyano-7-deazaadenosine) 
to the amide sangivamycin (74, 75) and many well characterized amidotransferases.  
Alternatively, the formal addition of ammonia to the nitrile of preQ0 can generate 
archaeosine directly, representing a unique class of amidotransferase chemistry as well as 
the only example of the conversion of a nitrile to a formamidine known in biology.  
 
Given the precedence of glutamine as the ammonia donor in amidotransferase reactions 
the activity was initially monitored in a coupled reaction to glutamine dehydrogenase in 
order to determine if any glutamate was being formed by observing the formation of 
NADPH.  NADPH formation was observed, providing the first evidence that MjTgtA2 
was capable of glutaminase activity.  Glutamate formation was also observed when [U-
14C]-L-glutamine was used and the assays were monitored by TLC.  The temperature 
dependence of glutaminase activity was investigated, and activity was observed to drop 
significantly at temperatures above 40 °C, which was surprising given that this protein is 
from a thermophile whose optimal growth temperature is approximately 85 °C (76).  
Enzymes from thermophiles typically exhibit low activity at ambient temperatures where 
the mesophilic enzymes exhibiting similar function are optimally active (77).  
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Additionally MjTGT, which catalyzes the preceding reaction, had already been shown to 
exhibit maximal activity at 80 °C (72).  The thermal stability of the protein was 
investigated by heating the protein for 15 minutes at different temperatures from 50 °C to 
80 °C.  Over 80% of the protein was found to stay in solution even when heated at 80 °C 
suggesting that the loss in activity at higher temperatures was not due to the protein 
precipitating out of solution at high temperatures.  Given the comparable glutaminase 
activity observed in the presence and absence of tRNA, it is likely that the assay 
conditions are not optimal, and this might explain the temperature sensitivity of the 
enzyme activity.   
 
Notably, MjTgtA2 was observed to utilize asparagine as well as glutamine as an 
ammonia donor, with glutaminase activity being ~4 fold higher than asparaginase 
activity. 
 
The glutaminase activity was determined in different buffers and varying pHs and it was 
observed that optimal glutaminase activity was found to occur in HEPES buffer (pH 7.0), 
but archaeosine formation was only found to occur at pH's greater than 7.  Archaeosine 
was also formed when either asparagine or NH3 was the substrate, however NH3-
dependent activity was optimal at higher pH, similar to what has been observed in other 
amidotransferases such as E. coli imidazole glycerol phosphate synthase (78).  Under 
basic pH conditions there is a higher concentration of NH3 from NH4Cl, which might 
explain why G+ formation was only observed at basic pH.  Most glutamine 
83 
 
amidotransferases have been found to be capable of substituting glutamine with NH3 (79, 
80).  However the formation of G+ in the presence of asparagine was surprising as only 
tRNA-dependent amidotransferases GatCAB and GatDE (81) have been shown to be able 
to use both glutamine and asparagine as nitrogen donors.   
 
Sequence and structural comparisons of MjTgtA2 with other amidotransferases exhibited 
no sequence or structural homology to either the class I, class II or GatCAB/DE enzymes, 
suggesting that the amidotransferase activity of TgtA2 evolved separately from all other 
known amidotransferase enzymes.  However a search for similar structures to the C1 
domain of MjTgtA2 resulted in multiple hits.  An intriguing similarity was found to 
Pseudomonas glutaminase-asparaginase, which catalyzes the hydrolysis of 
glutamine/asparagine to glutamate/aspartate.  The similarity of MjTgtA2 to the 
Pseudomonas glutaminase-asparaginase might explain MjTgtA2's ability to use both 
asparagine and glutamine as nitrogen donors. 
 
The biochemical analysis carried out on MjTgtA2 activity provides the first clear 
demonstration that the enzyme catalyzing the ultimate step in archaeosine biosynthesis is 
an amidotransferase that utilizes novel chemistry to achieve the transformation of a cyano 
group to a formamidine. 
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4.2 QueF 
 
QueF catalyzes the NADPH-dependent reduction of 7-cyano-7-deazaguanine (preQ0) to 
7-aminomethyl-7-deazaguanine (preQ1), a late step in the queuosine pathway (47).  QueF 
exhibits sequence homology to the type I GTP cyclohydrolases (GTP-CH-I) exemplified 
by E. coli FolE.  The homology between two protein families (Figure 55) resulted in an 
initial misannotation of QueF activity, however it was also used to predict that the two 
protein families belong to the same structural family, tunneling-fold structural family (47, 
56).  The discovery of QueF activity added a novel type of chemistry in the 
biotransformation of a cyano group to an amine, a common reaction in organic chemistry 
but which had never been observed in nature.  The activity of QueF places it in a class of 
enzymes traditionally known as NAD(P)+-dependent four-electron-transfer 
dehydrogenases (82).  Interestingly, these enzymes lack sequence homology and also 
employ distinctly different chemical mechanisms (71), but ultimately result in the 4-
electron reduction or oxidation of their substrate.   
 
The similarity between B. subtilis QueF and GTP-CH-I in sequence and multimeric 
quaternary structure resulted in a prediction that the active site of B. subtilis QueF would 
be in a similar location, i.e. at the intersubunit interface (56).  Based on the crystal 
structure of E. coli GTP-CH-I, a three-dimensional homology model QueF was built with 
a preQ0 molecule was docked in the putative active site (Figure 56).  In one monomer, the 
preQ0 interacts with the two invariant of Glu97 and Cys55, the two interactions are also 
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found in the structure of the GTP-CH-I-GTP complex.  Mechanistic studies previously 
carried out in our lab clearly demonstrated that (Cys55) (B. subtilis numbering) was 
involved in the formation of a covalent thioimide intermediate via reaction with preQ0 
(71), a mechanism for the reaction catalyzed by QueF was proposed based on the 
presence of a covalent intermediate (Figure 57).  The role of Glu97 was also investigated, 
a conserved residue in the QueF family (Figure 55).  Based on its position in the 
homology model Glu97 was implicated to play a role in anchoring bound preQ0 in the 
active site, similar to other T-fold proteins.  Steady state kinetic analysis of QueF Glu97 
mutants showed that the relative specific activity to wild type activity was in the range of 
1-6%, suggesting that Glu97 might play the predicted role of positioning preQ0 the active 
site of QueF as in other T-fold proteins (57).  Isotope labeling studies with 
stereospecifically deuterium labeled NADPH were utilized to determine the 
stereospecificity of the hydride transfer reaction catalyzed by QueF, demonstrating that 
the hydride transfer was pro-R specific.  Steady state kinetic isotope measurements 
indicated a primary isotope effect (kH/kD) of 2.59, suggesting that the chemical step of 
bond breaking of C-H in NADPH, transfer of the hydride and formation of the new C-H 
bond is at least partially rate-determining on the overall kcat of the reaction.   
 
The goal of this work was the transient state kinetic analysis of substrate binding and 
catalysis by QueF as well as the investigation of ligand effects on the quaternary 
structure.  Determination of the elementary rate constants allows the identification of the 
reaction(s) that limit the activity of QueF.  Data from steady state kinetic analysis 
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provides indirect information to define the pathway; however, because kcat and km are 
complex functions of individual rate constants, the individual reactions steps cannot be 
resolved under steady state conditions.  Transient kinetic methods allow examination of 
the reaction pathway where the enzyme is examined as a stochioimetric reactant, 
allowing individual steps in the pathway to be determined by direct measurement.  Single 
turnover experiments, which were utilized in elucidation of some of the rate constants, 
were performed under conditions in which the concentration of the enzyme is in excess of 
that of substrate.  These conditions ensure that a single enzymatic turnover of the active 
site can be measured directly without the concern that the substrate binding or product 
release step is rate limiting.   
 
Our proposed minimal kinetic mechanism for QueF is shown in Figure 9 a Bi-Uni-Uni-
Bi-Ter-Ter Ping Pong kinetic mechanism.  PreQ0 binding was determined in the wild 
type QueF as well as in the C55A mutant by monitoring the changes in the tryptophan 
fluorescence.  Thioimide formation was monitored at 370 nm under single turnover 
conditions.  For the data analysis we proposed a model based on previously established 
stability of the thioimide (71), which was found to be still present after several hours after 
dialysis.  This knowledge simplified the kinetics for preQ0 binding and subsequent 
thioimide formation, as the thioimide decomposition step was taken to be essentially 
irreversible on the time scale for pre-steady state kinetics.  The binding of preQ0 to QueF 
was initially determined and values found from this analysis were constrained in the 
calculation of thioimide formation rates.   
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In order to isolate the step(s) for NADPH binding and catalysis from preQ0 binding and 
thioimide formation, a preformed QueF-*PreQ0 complex for either the wild type or 
mutant E78A was used.  The first eight proposed rates (k1, k-1, k2, k-2, k3, k4, k-4) were 
directly measured in either absorbance or fluorescence based stopped flow experiments.  
We also attempted to measure the kinetics of NADP+ binding to QueF-*PreQ0 using 
fluorescence.  Unfortunately the results were difficult to interpret because the quenching 
of the tryptophan fluorescence in the presence of the thioimide is so large that it obscured 
any possible changes due to NADP+ binding, such that nothing conclusive was obtained 
from these experiments.   
 
Multiple turnover kinetics were carried out in order to investigate the rate of catalysis for 
the second hydride transfer.  From the multiple turnover analysis, only NADP+ 
dissociation and the second hydride transfer were calculated.  The thioimide covalent 
intermediate was used in the analysis such that the preQ0 binding was excluded from the 
equations defining the reaction observed.  NADPH binding previously determined was 
held constant and also assumed to be unchanged for two reduction cycles.  An enzyme 
isomerization step was proposed to occur after the binding of the second equivalent of 
NADPH; values calculated from the E78A proposed isomerization were used in the 
fitting.  In the end only the NADP+ dissociation and second reduction were calculated; 
these steps were proposed to be irreversible under the conditions of the experiment as 
attempts to determine rates of the reverse reactions resulted in values with very high 
coefficients of variation making it highly unlikely that the reverse reactions for these two 
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steps were significant under the experimental conditions.  The results from the kinetic 
analysis indicate that the binding of preQ0 and NADPH to QueF, as well as thioimide 
formation, are very rapid; and that reduction of the thioimide is most likely the rate 
limiting step.  Analysis of component rates suggests structural changes occur between 
these steps, further limiting the overall rate. 
 
The structure of QueF was recently solved providing crystallographic evidence of the 
formation of the thioimide between Cys55 and preQ0.  Surprisingly, the crystal structure 
also revealed the presence of Mg2+ ions at the subunit interface between the two 
pentamers.  Previously, activity analysis with divalent metals suggested that they did not 
have any effect on enzyme activity.  However the presence of the Mg2+ in the crystal 
structure led to further investigation of a possible role of divalent metals in QueF 
assembly and activity.  The activities of the native enzyme and its apparent apoprotein 
were determined in the presence of divalent metals as well as in the presence of EDTA.  
The presence of divalent metals was shown to increase QueF activity while addition of 
EDTA resulted in a decrease of QueF activity.  The effect of KCl was also determined, 
and concentrations greater than 100 mM were found to inhibit activity as previously 
shown (71).  The effect of divalent metals on the activity of the protein suggested that, as 
observed in the crystal structure, the presence of a divalent metal is important to maintain 
the quaternary structure of QueF.  Given the positions of the Mg2+ ions it seems unlikely 
that the divalent metal plays a direct role in catalysis.  The QueF "apparent apoprotein" 
was found to have lower activity than native protein.  The activity observed for the 
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apparent apoprotein could be due to tightly bound metal that was not removed by the 
demetallating process; however this was not confirmed.  It could also imply that the 
presence of the metal is not essential for quaternary structure, but that it helps to stabilize 
the quaternary structure allowing the reaction to take place more readily.  The inhibitory 
effect observed by KCl at high concentrations might indicate some disruption of the 
quaternary structure.  This is consistent with the observation that this effect is greatly 
attenuated when the reaction is carried out in the presence of divalent metals.   
 
In order to further investigate the effects of the metals on the QueF structure, analytical 
size exclusion chromatography was carried out.  One of the greatest limitations of size 
exclusion chromatography is that resolution of the emerging peaks is limited (83).  Gel 
filtration is a relative technique, requiring calibration using molecular weight standards.  
However, when a heterogeneous system is analyzed it is not always possible to resolve 
intermediates that are present in the population being analyzed.  Size exclusion analysis 
of a multimeric protein such as QueF is complicated by the increased probability that 
multimers of the subunits might be present in different multiplicities.  Close analysis of 
Figure 35A reveals an asymmetrical peak, which is characteristic of a heterogeneous 
population where a sharp leading edge and an extended trailing edge is expected for 
rapidly equilibrating species (84).  A system in rapid equilibrium between two or more 
states cannot be resolved into the different species present in the population if the rate of 
exchange of the conformers is much faster than the characteristic time of the 
chromatography.  However, when the transition between the different conformations is 
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sufficiently slower than the time of analysis, it is possible to show the presence of more 
than a single peak in a chromatographic run.  The peak for QueF alone was observed to 
be broad, particularly when compared to the one obtained when QueF was preincubated 
with preQ0, i.e. QueF with thioimide present.  The elution of QueF-*PreQ0 earlier than 
QueF alone suggests that there is either a change in the conformation of the protein when 
the thioimide is made or that there is a shift in the equilibrium of the QueF population.  
As gel filtration is a technique that is based on correlation of the measured retention time 
and Stokes radius of a protein (85), any change in conformation that changes the radius 
would also affect the retention time.  Close analysis of the QueF-*PreQ0 (Figure 36A) 
peak (8.33 min) reveals that while it is narrower than in the absence of preQ0 it possesses 
a shoulder, suggesting that though the equilibrium is shifted towards the decamer, there is 
still a small fraction of the population that exists as a pentamer.  Interestingly, a less 
pronounced peak was also observed eluting at about 10.4 minutes.  The retention time 
and UV spectrum of this peak (Figure 36C) is consistent with the presence of a QueF 
monomer that has the thioimide present.  Given that the monomer was clearly resolved 
from the multimeric peak it suggests that upon injection a fraction of the population was 
already present as monomer units.  Attempts to collect the decamer QueF-*PreQ0 peak 
and reinject it to determine if the monomer was originating from dissociation of the 
decamer were inconclusive as a broad peak was observed, suggesting a requilibration of 
the system between the decamer and pentamer states.  The monomer subunit observed 
might also be due to possible equilibrium between monomers and the multimeric 
complexes, such that even if the monomer is unable to form the thioimide on its own, the 
91 
 
existing equilibrium between the monomers and multimers result in part of the monomer 
population having a thioimide present.  The two possible pathways for formation of the 
thioimide found in the monomer cannot be distinguished by gel filtration. 
 
When a QueF sample was exposed to 0.5 M KCl in the absence either Mg2+ or Mn2+ ions, 
the protein was found to fall apart readily but a fraction of the population remained intact 
to give the decamer peak (data not shown).  However, when QueF previously equilibra-
ted with Mg2+ was incubated in the presence of 0.5 M KCl and 10 mM EDTA, it resulted 
in two distinct peaks, a peak for the multimeric protein, which eluted later than when the 
analysis was carried out in the presence of low salt, and a peak corresponding to the 
monomer subunit.  The elution of the peak corresponding to the multimeric protein at a 
later time is an indication that at high KCl concentrations, the equilibrium is shifted 
towards the pentameric state of the protein from the decamer.  The mass of this peak was 
calculated to be approximately 150 kDa, which is an average of the masses of the 
pentamer and decamer oligomers.  The presence of a clear peak for the monomer unit 
shows that a significant amount of protein is dissociated and suggests that the equilibrium 
between the monomer and multimeric forms of the protein is slow, as it is possible to 
separate the different populations on the time scale of the experiment, which would not 
be the case if there was a rapid exchange.  These results suggest that the QueF population 
is not uniform and that there is a dynamic equilibrium between different forms of the 
protein.  The binding of small inorganic ions has been shown to cause protein 
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dissociation in other systems, such as the dissociation of tryptophanase in the presence of 
monovalent cations (86). 
 
Two types of associations are found in macromolecules, static and dynamic.  Static 
associations are slow, making it possible to distinguish the different states that constitute 
the population (87).  Dynamic associations occur very rapidly (87) and it is not possible 
to separate the various components of the population, such that an average is observed, 
which appears to be what we see in gel filtration analysis of QueF.  Analytical 
ultracentrifugation and the technique of sedimentation equilibrium can be used to 
determine the native molecular weight of oligomeric proteins as well as in the 
investigation of interacting systems, and is the method of choice in analyzing dynamic 
interactions as it provides information about signal-average buoyant molar mass (87).  
Sedimentation equilibrium is an absolute technique for molecular weight measurement; 
since the shape of the macromolecule does not affect the measurement.  When 
sedimentation equilibrium (by collaborators Swairjo Group) analysis was carried out on 
QueF, it was observed to migrate with an apparent Mr of 182 kDa, lower than the 
theoretical Mr of the decamer (194 kDa), suggesting the presence of smaller multimeric 
species.  When fitting the data assuming two multimeric species in equilibrium, pentamer 
and decamer, the apparent Kd for the pentamer-decamer equilibrium was calculated to be 
140-240 nM.  There was no indication of a higher molecular weight aggregate for the 
native protein.  The QueF-*PreQ0 complex ran with an apparent average Mr 189 kDa, 
indicating a shift in equilibrium toward the decamer.  The apparent Kd for decamer 
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formation is 35-37 nM, lower than that of the QueF enzyme alone, indicating a substrate-
induced tightening or stabilization of the decamer.   
 
In transient kinetics when the kinetics of substrate binding is very fast, the observed 
kinetics are a reflection of the rate of catalysis at the active site (88).  Stopped-flow 
methods are typically applied when there is an observable signal, the most commonly 
used being absorbance or fluorescence.  These two signals are limited mainly by the fact 
that the concentration of the substrates is dictated by the extinction coefficients and 
quantum yields (89), but averaging of several reaction traces significantly increases the 
ratio of signal to noise (S/N).  Fluorescence has the disadvantage that it is difficult to 
obtain stoichiometric amplitude data.  
 
Proteins exhibit intrinsic fluorescence due to the presence of phenylalanine, tyrosine and 
tryptophan.  QueF sequence analysis revealed that it only contains one tryptophan residue 
and the crystal structure revealed that the tryptophan residue was ~ 20 Å from the active 
site cysteine residue.  Therefore, any change in the tryptophan fluorescence would be a 
reflection of structural changes occurring in the protein and not due to tryptophan directly 
interacting with the preQ0.  Tryptophan is particularly useful as it is very sensitive to its 
immediate environment and can be used in monitoring conformational changes, subunit 
associations, and substrate binding, as these processes can be accompanied by changes in 
its emission spectra (90).  Tryptophan fluorescence can be selectively excited at 295 - 
305 nm (90), in all the tryptophan fluorescence assays for substrate binding tryptophan 
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was excited at 295 nm.  Analysis of the microenvironment (4 Å) of the tryptophan 
residues in two subunits (in the presence and absence of preQ0) revealed two major 
differences (Figure 58); first an aspartic acid residue is present in very close proximity to 
the tryptophan residue in the subunit without preQ0 but not in the subunit with preQ0.  
Second, methionine and lysine residues are present close to the tryptophan in the subunit 
with preQ0 bound to it but not in the subunit without preQ0.  The emission spectra of 
QueF in the presence and absence of preQ0 were obtained, and quenching of the 
tryptophan fluorescence was observed in the presence of preQ0 as well as a shift in the 
emission maxima, consistent with the changes in the QueF structure upon preQ0 binding. 
 
In the wild type QueF a covalent intermediate is formed.  In order to investigate whether 
the quenching observed was due to thioimide formation or preQ0 binding, fluorescence 
measurements were made with the C55A mutant.  The fluorescence of C55A, which 
lacks the cysteine residue required for the formation of the thioimide, was shown to be 
reduced in the presence of preQ0, supporting the hypothesis that the binding of preQ0 to 
QueF is accompanied by conformational changes in the protein.  Stopped flow analysis of 
tryptophan fluorescence indicated that the fluorescence change in the wild type QueF was 
biphasic while the change in the C55A mutant was monophasic.  The biphasic profile 
suggested that the observed fluorescence quenching was due to at least two events 
occurring upon the mixing of QueF with preQ0.  Non-linear regression analysis of the 
fluorescence data from the experiments carried out with wild type and mutant showed 
that the fast phase in the binding of preQ0 to the wild type gave a comparable rate to the 
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calculated rate of preQ0 binding observed in the C55A mutant (1.32 µM-1s-1 and 1.06 µM-
1s-1 respectively).   
 
Stoppped flow kinetic analysis was also determined for thioimide formation.  
Interestingly, the rate of thioimide formation (2.55 s-1 at 30 °C) was observed to be 
similar to the value determined for the slow phase in tryptophan quenching (1.3 s-1 at 20 
°C), indicating that the further quenching observed in the wild type protein and not in the 
C55A mutant was due to thioimide formation.  The preQ0 binding experiments monitored 
by tryptophan fluorescence were determined at 20 °C instead of 30 °C because the fast 
phase of the preQ0 binding was almost completely absent from the experiments 
determined at 30 °C, such that the quenching observed was mainly due to thioimide 
formation.  No significant differences in the crystal structures of the QueF with preQ0 
bound and the one with the thioimide formed were observed, suggesting that no 
additional structural changes take place as a consequence of thioimide formation.  
Therefore, the slow second phase in the tryptophan fluorescence is formation of the 
thioimide, that locks the protein in the QueF-*PreQ0 conformation thereby the shifting 
the equilibrium towards the QueF.PreQ0 binary complex.  The equilibrium between the 
free QueF and QueF.PreQ0 complex, which is apparent within a few milliseconds of 
mixing preQ0 with the C55A mutant, is therefore not reached immediately due to the 
thioimide formation.   
 
96 
 
Thioimide formation was directly followed by absorbance at 370 nm. Fitting a simple 
two step mechanism to the thioimide formation resulted in residuals that were non-
random from a global analysis of the data (Figure 44C), suggesting that the mechanism of 
thioimide formation was more complex.  Given our knowledge of the presence of a pre-
existing equilibrium between the pentamer and decamer states of the protein, a step 
indicating such an equilibrium was added to the mechanism and this dramatically 
improved the residuals, suggesting that the pre-existing equilibrium between the different 
states of the protein might influence the kinetics observed.  The need for a pre-existing 
equilibrium in fitting the thioimide data was unexpected as this was not necessary when 
preQ0 binding data was analyzed.  It is also possible that more than one form of QueF is 
able to form the thioimide, although we have is no direct evidence that addresses this 
issue.   
 
Thioimide formation under single turnover conditions was shown to fit well to a single 
exponential equation in analyses using Kaleidagraph.  However, when the preQ0 
concentration was greater than the QueF concentration a second exponential rate was 
observed.  Examples of this are shown in Figures 44D - F.  The appearance of a second 
rate was not expected.  The fast phase observed under single turnover conditions could be 
due to the reaction occurring between QueF in a more reactive conformation.  In theory, 
preQ0 could bind to either the pentamer or decamer states.  Given the more open nature 
of the pentamer, the reaction might occur more readily in this state than in the decamer.  
It is clear though that the binding of preQ0 shifts the equilibrium to the decamer state.  
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The presence of a small population of monomer QueF-*PreQ0 observed in the gel 
filtration analysis might also be an explanation for the second rate observed in thioimide 
formation.  There might be a fraction of the population that is still able to react with the 
preQ0 but is slower than the predominant form.  Though it seems unlikely, a monomer 
subunit of QueF might form the thioimide, when there is excess preQ0 in solution such 
that the more reactive population has already reacted.  This argument is consistent with 
the observation that the thioimide formation is strictly monophasic at low preQ0 
concentrations.  The presence of the second rate might also be due to re-estabilishing the 
equilibrium of the pentamer and decamer states of the protein accompanied by changes in 
extinction coefficient such that an increase in absorbance is observed.  The thioimide 
formation was determined on two different instruments in order to check if the residual 
pattern was an artifact due to the instrument.  However the same residual pattern was 
observed, suggesting that the observation of the non-random residuals was not due to the 
stopped flow instrument drifting but a characteristic of the reaction being observed.  
 
The kinetics of NADPH binding were determined by following the fluorescence of 
NADPH, which is quenched upon binding to protein.  Association and dissociation 
constants of NADPH to the E78A-*PreQ0 complex were determined under pseudo-first 
order conditions.  The QueF mutant was used in order to look at the binding kinetics 
completely separate from NADPH oxidation.  The kinetics observed were biphasic. 
Initial attempts to fit the data to a single exponential decay resulted in poor fitting, while 
fitting with a double exponential decay produced a better fit.  We propose that the fast 
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phase corresponds to the association and dissociation of the NADPH from the protein 
complex, while the slow phase is due to either isomerization of the binary complex 
(QueF-*PreQ0.NADPH) or it can also be an artifact of the E78A mutation since this 
residue interacts directly with preQ0 and it is substituted with alanine which is unable to 
make the same interactions.  The biphasic change noted in this protein, which is unable to 
reduce the thioimide in the active site, has been previously observed in other 
dehydrogenases such as aldolase reductase (91), acetohydroxy acid isomeroreductase 
(92), human aldolase reductase (93) where changes in conformation upon the binding of 
NADPH have been suggested to also occur.   
 
The rate of reduction of the thioimide was analyzed using both fluorescence and UV 
absorption analysis.  Direct monitoring of the loss of NADPH absorption at 340 nm, as 
done previously in the steady state analysis of QueF (71), could not be used under single 
turnover conditions because of the overlap of the thioimide peak with that of NADPH 
(Figure 47).  The kinetics of thioimide loss followed at 390 nm under single turnover 
conditions fit well to a single exponential decay.  The change in absorbance at 390 nm 
was monophasic, an indication that the observed change was most likely due to a single 
event taking place, in this case the reduction of the thioimide.  When fluorescence of 
NADPH was used as the reporter, the association and dissociation of NADPH was 
observed as the fast phase.  The value of association of NADPH with QueF-*PreQ0 
complex was found to be 0.06 µM-1 s-1, which is less than that measured for E78A (0.2 
µM-1 s-1).  This might be due to differences in the size and polarity of the R-groups of the 
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two residues.  Even though E78 appears not to directly interact with the NADPH in the 
crystal structure, having alanine in that position might make it more accessible for the 
NADPH binding because of its smaller R-group even though the mutation results in an 
inactive protein.  The data for the single turnover of NADPH was fit to a double 
exponential decay, suggesting that under single turnover conditions there are at least two 
events taking place, the binding of NADPH and its subsequent oxidation in the reduction 
of the thioimide.  This model was also supported by the data obtained from loss of the 
thioimide absorbance observed at 390 nm under single turnover conditions.  The rate for 
the reduction of the thioimide was found to be comparable from both fluorescence and 
UV data suggesting that the proposed two step model is possible where an enzyme 
isomerization does not take place.  The apparent absence of an isomerization step under 
single turnover conditions might be either because it induces such a subtle change in the 
protein complex that it makes it difficult to detect or that in the native protein the 
isomerization step occurs so fast that it does not change the overall kinetics being 
observed.  The apparent isomerization in the E78A mutant might also be an artifact due 
to the mutation.   
 
Multiple turnover kinetics of QueF was analyzed.  Proposing a model for the calculation 
of rate constant was difficult.  QueF-*PreQ0 was used in order to reduce the steps to be 
determined; other constraints on the model included the experimentally measured value 
for the first reduction of the thioimide, which was held constant, as well as the binding of 
the second NADPH, which was assumed to be identical to the first NADPH.  The 
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presence of a single NADPH site for two preQ0 sites, and two reduction cycles for each 
preQ0 site, complicated the analysis.  Some questions were difficult to answer, including 
the following: are the two sites equivalent? Upon binding of the second equivalent of 
NADPH, does the intermediate from the first reduction preferentially get reduced over 
the thioimide or is this still random?  Does the protein undergo structural changes in 
order to accommodate the reduction of the intermediate?  The affinity for the enzyme for 
NADP+, which could affect its rate of diffusion, is also unknown at this point.   
 
The data obtained for the multiple turnover experiment was complex (Figure 59) and it 
was not possible to fit simple decay equations to the data obtained.  In the presence of 
low NADPH concentrations, the data could be fit to a double exponential decay.  
However, as the concentration was increased, the shape of the plot changed.  The data 
was analyzed using Dynafit for a global fitting.  The initial fast phase found in all the 
traces was attributed to the binding of NADPH and its subsequent quenching. However 
the almost constant fluorescence signal at higher NADPH concentrations might be due to 
several factors, which include, but are not limited to, the following: after the initial 
reduction of the thioimide, the NADP+ does not readily diffuse away, it might require a 
conformational change to take place before it can diffuse or the binding of the second 
equivalent of NADPH is accompanied by conformational changes.  Alternatively the 
apparent constant fluorescence at high NADPH concentrations might be due to the excess 
NADPH which has a higher quantum yield than protein bound NADPH which is 
associated with any of protein.  Only the k2 and k5 were calculated from the multiple 
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turnover data analysis and all other constants were determined by other experiments and 
were held constant for the analysis. 
 
The transient kinetic analysis results indicate that the binding of preQ0 and NADPH to 
QueF, as well as thioimide formation are very rapid.  Reduction of the thioimide and 
imine intermediate are most likely the rate-limiting steps, and analysis of component 
rates suggest that structural changes occur between these steps, further limiting the 
overall rate.  Structural analysis of QueF indicates that this protein exists in equilibrium 
between the pentamer and decamer states.  There is also evidence that there might be 
small fraction of the protein which exits as a monomer which is in equilibrium with the 
multimeric proteins.  The addition of preQ0 or divalent metals results in stabilization of 
the decamer structure.  All the data combined is consistent with structural changes taking 
place after addition of a substrate. 
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4.3 QueA 
 
Previous work carried out has shown that the formation of the C-N bond occurs at C4’, 
which led to our proposed mechanism.  Proton abstraction could occur by two possible 
routes which are shown in Figure 12.  The first mechanism shows that deprotonation 
occurs prior to formation of the C-N bond while the second mechanism shows that the C-
N bond is formed first before the C5’ proton is removed, resulting in an SN2 mechanism. 
Even though the SN2 mechanism is simpler, such a reaction at a secondary carbon is 
highly unfavorable, and therefore the mechanism is more likely to occur by an 
elimination/addition mechanism that makes use of the favorable pKa in the first step.  In 
the SN2 mechanism the known stereochemistry of the oQ limits this mechanism to only 
procede with loss of the pro-R proton. 
 
Elimination/addition mechanism is compatible with loss of either the proR or proS 
hydrogen since the stereochemistry at C5’ is lost.  However, elimination/addition 
mechanism requires syn or anti relationship between the proton removed and the C4’-O 
bond.  The conformation about the C4’-C5’ bond AdoMet indicates that the mechanism 
would most likely favor loss of proS hydrogen. 
 
During the transfer of the ribosyl group from AdoMet to form oQ, one of the hydrogens 
at the C5’ position is lost.  Elucidating the stereochemistry of this reaction is fundamental 
to understanding the mechanism of QueA.  To investigate the stereospecificity of QueA, 
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stereospecifically labeled deuterated AdoMet was used to determine if the proton 
abstraction was stereospecific. PreQ1-tRNA, which had been converted to oQ-tRNA, was 
digested as previously described (63), and chromatograms showing the products of these 
digestions are shown in Figure 51.  oQ samples generated from 5’R-[5’D]-AdoMet, 5’S-
[5’D]-AdoMet and unlabeled AdoMet were all lyophilized and analyzed by mass 
spectrometry. The results of these analyses are shown in Figure 52.  
 
The results obtained from mass spectrometry analysis were consistent with an 
elimination/addition mechanism in which the proS hydrogen is lost.  Loss of the 
deuterium was shown in the oQ prepared using proS AdoMet, which resulted in a mass of 
426 m/z the same as the one obtained when unlabeled AdoMet was used, while the oQ 
prepared using proR AdoMet was 427 m/z, consistent with loss of the proS proton as the 
deuterium label was retained in this sample (Figure 52).  The results obtained support an 
elimination/addition mechanism. 
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Tables and Figures 
   
 
Figure 1: The structures of the 7-deazaguanosine hypermodified nucleosides of transfer RNA.   
Figure taken from (37). 
            
Figure 2: Class 1 tRNA canonical structure.   
(A) Nucleotides 15 and 48, forming the Levitt base pair. (B) Ribbon representation of the yeast tRNAPhe 
structure.  Figure taken from (24). 
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Figure 3: Electron density difference in the base plane between [Mg(H2O)5G]2+ and the simple G 
base.  
(A) archaeosine (fa7d7G) (B) G base.  Figure taken from (24) 
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Figure 4: The biosynthetic pathway of the preQ0.   
Figure taken from (45). 
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Figure 5: The biosynthetic pathways of archaeosine and queuosine in archaea and bacteria. 
Figure taken from (41). 
 
 
 
 
 
                                   
      
 
Figure 6: QueF catalyzed reaction. 
 
 
              
Figure 7: Multimeric barrels by the T
The monomer units are shown in color.  (A) 6
Urate oxidase (UOX) (tetramer)
ase I (GCYH I) (decamer). The enzymes are composed of barrels superposed face to face
from (57). 
 
   
 
                  
 
Figure 8: Different pathways of nitrile metabolism. 
Figure adapted from (58) 
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Figure 9: Proposed kinetic scheme of QueF based on the Bi-Uni-Uni Ter-Ter Ping Pong kinetic 
mechanism 
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Figure 10: QueA catalyzed reaction.  
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Figure 11: QueA follows an ordered Bi - Ter mechanism. 
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Figure 12: Possible Mechanisms of the QueA Reaction Consistent with C-N bond formation at C4’. 
 
                  
 
 
Figure 13: Conformations about the C4’-C5’ bond of AdoMet. 
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Figure 14: PreQ0 semi-preparative HPLC purification.  
PreQ0 was purified on a semi-preparative Luna C18 column (250 x 10 mm, 5 µm) from Phenomenex.  The 
preQ0 eluted in a 20 minute run, eluting at 12.5 minutes under gradient conditions; 96% 25 mM NH4OAc 
(pH 6.0)/4% methanol for 10 minutes followed by a gradient of 96% 25 mM NH4OAc/4% methanol up to 
85% 25 mM NH4OAc/15% methanol over 10 minutes at a flow rate of 4 mL/min . 
 
                             
  
Figure 15: Schematic of a stopped flow instrument. 
 
PreQ0 
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Figure 16: Analysis of the TgtA and TgtA2 families.  
A) Predicted role of TgtA2 in archaeosine biosynthesis.  B) Clustering of tgtA and tgtA2 genes in Archaea. 
C) Shared modular structure of TGT and TgtA2 proteins. Only the long (full-length) forms are shown. The 
active site and known catalytic residues of TGT (P. horikoshii numbers) and the conserved TgtA2 motif 
(M. jannaschii numbers) in the presumably catalytic C1 domain (starred) of TgtA2 are shown. The zinc-
binding residues are found in all but six TGTs and in ∼60% of the TgtA2 sequences analyzed. Figure taken 
from (70) 
  
                             
 
Figure 17: SDS-PAGE analyses of 
lane 1, MW marker; lane 2, cell lysis free extract; lane 3, CFE after heating at 60 
heating a 75 ºC; lane 5, Trx-his
MjTgtA2 
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MjTgtA2 purification.  
ºC; lane 4, CFE after 
6-MjTgtA2; lane 6, Self cleaved MjTgtA2; lane 7 purified C
 
-terminal his6-
 A) 
 
 
 
 
B)      
MSDKIIHLTDDSFDTDVLKADGAILVDFWAEWCGPCKMIAPILDEIADEYQGKLTVAKLNIDQNPG
TAPKYGIRGIPTLLLFKNGEVAATKVGALSKGQLKEFLDANLAGSGSGH
GMKETAAAKFERQHMDSPDLG
 
C)   
MLEPIAYDIGRLCKEEDKELTPKLIDIDVIGLSQEKIFYGIMTPFRCPNSKSIYELRKSYVKADGIKMP
FDTFRELTSIFKKSFIGTVKYKGNVFKYQILNFGKHVDLIELEDADLYIIADGRRLIERKELQIIPKIR
EKISPNSAIYSPAVFPWEIPLLAYIGVDYFDDSLAKLYASMGYKFTKNRAVKVDSFSFEELYNNNK
KVYEEILEEVRIAIKNGFLRNVVEETAVSHPYLWANYRRYEPDLRNIPLSKE
YLERLDNYEPYSNIIVLLPCSSKKPYSISQSHQKFIKAIKSAKVVVEEVILTSPYGLVPRALERLVNY
DIPVTGEWSFEEIELINNCLKNFLKKVKEKFDDYIVIAHLPEHYLEILELDDIVITSKGNPTSEEALKN
LTDTLKKYKELTKSKDINKKGQRIHNIQQLAEFQFGINFIPNEIFINHKGQIFTKINNKNQQIASINPK
NGLLILTLSGGELLWNSGGKDINYIEVNYEIKKG
ALMSGFEMKKAKHGALVNIRNVKS
 
Figure 18: Edman degradation 
(A) SDS-PAGE indicating the bands sequenced by Edman 
Self cleaved MjTgtA2; lane 3
(from the pET32/Xa LIC vector) indicating the site of proteolysis in bold and underlined. (C) 
native sequence indicating the site of proteolysis in bold and underlined, the ita
proteolysis. 
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MHHHHHHSSGLVPRGS
TGGGSGIEGR 
NKIIVTTNINIPEVKK
SLFPPGFVDCNENISYNDEVVLIKDDTFLGIGR
 
of MjTgtA2 bands. 
degradation, lane 1, Trx-his
, purified C-terminal his6- MjTgtA2. (B) Thioredoxin Fusion tag sequence 
lics indicate the other site of 
6- MjTgtA2; lane 2, 
MjTgtA2 
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Figure 19: HPLC gel filtration analysis of Thioredoxin-His6 MjTgtA2 and cleaved MjTgtA2. 
MjTgtA2 (discontinuous line) elutes at 8.75 minutes and cleaved MjTgtA2 (continuous line) elutes at 8.88 
minutes. Inset: standard curve presented as log MW vs. KD. The standards used in the calibration included; 
Carbonic Anhydrase (29KDa), BSA (66 KDa), Alcohol Dehydrogenase (150 KDa), β-Amylase (200 KDa), 
Apoferritin (443 KDa) and Thyroglobulin (669 KDa). Each data point represents the average of 2 trials. 
The protein standard data fit the linear regression y =4.111- 3.245 x (R=0.967). Determined Molecular 
mass of Thioredoxin- His6 MjTgtA2 was 154 KDa (Calculated for dimer 155 kDa). Determined molecular 
mass of cleaved MjTgtA2 122 KDa (Calculated for cleaved dimer 114 kDa). 
 
                                                                   
 
Figure 20: Purification of tRNASer from prep cell.  
                                 
Figure 21: Glutaminase activity of 
NADPH formation was monitored at 340 nm. 30 and 60 µg of protein were used, in a solution containing 
50 mM phosphate (pH 7.5), 0.5 M NaCl, 20 µM preQ
1 mM NADP+ and 4 U of glutamate dehydrogenase at 37 
 
 
 
                           
                 
Figure 22: Glutaminase activity as a function of increasing concentration of 
Reaction conditions; 100 mM 
MgCl2, 2 mM DTT, 12.4 µM [(U)
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MjTgtA2 coupled with glutamate dehydrogenase activity
0-tRNASer, 15 mM MgCl2, 1 mM DTT, 2.5 mM Gln, 
ºC.  
 
 
MjTgtA2
HEPES (pH 7.0), MjTgtA2 (MJ1022) (2.0 – 20 µg). 0.5 M NaCl, 15 mM 
-
14C]-L-Gln, 20 µM preQ0-tRNASer 
. 
. 
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Figure 23: Temperature profile determination of MjTgtA2. 
Reaction conditions; 100 mM HEPES (pH 7.0), 0.5 M NaCl, 20 mM MgCl2, 1 mM DTT, 10 µM [(U)-14C]-
Gln and 20 µM preQ0-tRNASer, 7.8 µg MjTgtA2  
 
 
 
 
                           
Figure 24: pH profile determination of MjTgtA2. 
Reaction conditions; 100 mM Tris/Mes/Acetate, 0.5 M NaCL, 20 mM MgCl2, 1 mM DTT, 10 µM [(U)-
14C]-Gln and 20 µM preQ0-tRNASer, 7.8 µg MjTgtA2. 
118 
 
   
                          
 
Figure 25: Activity of MjTgtA2 in different buffers. 
Reaction conditions; 100 mM buffer, 0.5 M NaCl, 20 mM MgCl2, 1 mM DTT, 10 µM [(U)-14C]-Gln and 
20 µM preQ0-tRNASer, 7.8µg MjTgtA2  
 
                             
Figure 26: Asparaginase activity of MjTgtA2. 
Reaction conditions; 100 mM HEPES (pH 7.0), MjTgtA2, 0.5 M NaCl, 15 mM MgCl2, 2 mM DTT, 12.4 
µM [3H]-L-Asn, 20 µM preQ0-tRNASer 
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Figure 27: HPLC analysis of tRNA nucleosides from MjTgtA2 activity. 
Amidotransferase activity was determined in the presence of NH4Cl, Gln  or Asn at 40 ºC.  The tRNA was 
purified and digested as previously stated and analyzed on HPLC. (A) Reversed phase HPLC separation of 
nucleosides from preQ0-tRNASer (red) and G+-tRNASer (blue). (B) PreQ0 characteristic chromophore. (C) 
Archaeosine characteristic chromophore. 
C. B. 
A. 
  
 
 
Figure 28: ESI mass spectrum 
(A) G+ Mr calculated, 324, MH
calculated mass 307, MH+ ion 308.
 
 
A. 
 
 
 
 
 
 
 
 
 
 
B. 
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of nucleosides archaeosine and preQ0 nucleoside 
+
 ion 325, Mr of the neutral base of G+ 192, BH2+ ion 193.  (B) PreQ
 
 
 
0 
                    
               
Figure 29:  SDS/PAGE analyses of QueF purification
lane 1 , MW marker ;  lane 2  , cell lysis free extract
His6-QueF. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30: SDS/PAGE analyses of 
lane 1, MW marker ; lane 2, Wild type QueF; lane 3,
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 by Ni2+-NTA agarose chromatography
; lane 3, flow through; lane 4, wash 
cleaved QueF proteins. 
 C55A mutant; lane 4, E78A mutant
. 
; lane 5, purified 
 
      
Figure 31: Effect of Divalent metals on native QueF activity
Reaction conditions: 100 mM Tris
preQ0, 1 µM QueF, and the divalent metal (0 to 10 mM) 
was monitored at 340 nm. 
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. 
-HCl (pH 7.5), 100 mM KCl, 1 mM DTT, 80 µM NADPH, 
at 30 ºC.  The change in absorbance of NADPH 
 
150 µM 
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Figure 32: Effect of Divalent metals on demetallated QueF activity. 
Reaction conditions: 100 mM Tris-HCl (pH 7.5), 100 mM KCl, 1 mM DTT, 80 µM NADPH, 150 µM 
preQ0, 1 µM QueF, and the divalent metal (0 to 10 mM) at 30 ºC.  The change in absorbance of NADPH 
was monitored at 340 nm. 
 
A. B. 
C. 
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Figure 33: Effect of KCl concentration on QueF activity. 
A) Native QueF B) Apoprotein 1) 100 mM KCl 2) 50 mM KCl 3) 10 mM KCl 4) 100 mM KCl and 0.25 
mM MnCl2 5) 50 mM KCl and 0.25 mM MnCl2 6) 10 mM KCl and 0.25 mM MnCl2. Assay conditions; 
100 mM Tris-HCl, 1 mM DTT, 80 µM β-NADPH, 150 µM preQ0, 1 µM QueF and KCl varied. 
 
  
A. 
B. 
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Figure 34: pH profile determination of QueF  
Assay conditions:  100 mM Buffer, 50 mM KCl 1 mM DTT, 80 µM β-NADPH, 100 µM preQ0, 2 µM 
QueF, and 250 µM MnCl2 reaction was carried out at 30 °C 
(A) MES (pH 5.75 - 6.55) and Tris-HCl (pH 7.0 - 8.0) (B) potassium phosphate  
  
A. 
B. 
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Figure 35:  HPLC analytical gel filtration analysis of QueF. 
(A) QueF alone elutes at 8.57 min (B) QueF alone in the presence of 0.5 M KCl and 10 mM EDTA elutes 
at 8.78 min and at 10.4 min. 
 
  
A. 
B. 
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                       .     
 
          
 
Figure 36:  HPLC analytical gel filtration analysis of QueF-PreQ0 complex. 
(A) QueF-PreQ0 complex elutes at 8.33 min (B) Spectrum at 8.33 min i.e decamer (C) Spectrum at 10.4 
min (monomer). 
 
A. 
C. 
             
 
 
Figure 37: B. subtilis QueF Homodecamer
One subunit is highlighted in red. Mg
shown in cyan.  Bound glucose sulfate or glucosamine found in the non
green in the NADPH binding pocket.
 
                         
 
 
Figure 38: Crystal structure of QueF 
One subunit is highlighted in blue, the thioimide is shown in red.
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.  
2+
 ions are shown as magenta spheres.  Bound preQ
-covalent complex is shown in 
 
 
pentamer. 
 
 
0 molecules are 
                     
 
Figure 39: Thioimide formed in the active site of QueF
                
 
Figure 40: QueF Cofactor Binding site 
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Figure 41: QueF and NADPH Fluorescence. 
Excitation of QueF at 295 nm and of NADPH at 340 nm is shown. (A) 50 mM phosphate (pH 6.5), 50 mM 
KCl, 1 mM DTT, 250 µM MnCl2, 80 µM QueF and 100 µM preQ0 (the solid line) and without preQ0 
(broken line).  (B) NADPH fluorescence.  
 
A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B. 
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Figure 42: Transient state analysis of tryptophan quenching upon preQ0 binding to C55A.  
(A) Global analysis of preQ0 binding (final concentrations in reaction: 200 µM QueF, 50 mM potassium 
phosphate (pH 6.5), 50 mM KCl, 250 µM MnCl2, 1 mM DTT and preQ0 (6.8, 11.8, 18.2, 23.3, 29.2, 38.8, 
50.0 µM). The reaction was carried out at 20 °C. (B) residuals for the fit at 38.8 µM preQ0. Time is in 
seconds. 
A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B. 
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Figure 43: Transient state analysis of tryptophan quenching upon preQ0 binding to wild type QueF. 
 
(A) Global analysis of preQ0 binding (final concentrations in reaction: 200 µM QueF, 50 mM potassium 
phosphate (pH 6.5), 50 mM KCl, 250 µM MnCl2, 1 mM DTT and preQ0 (5.3, 15.4, 22.6, 30.4 µM). The 
reaction was carried out at 20 °C. (B) residuals for the fit at 15.4 µM preQ0. Time is in seconds. 
 
A. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B. 
         
                                                                        
             
 
           
 
Figure 44: Absorbance measurements of 
conditions.   
(A) Global analysis of thioimide formation 
potassium phosphate (pH 6.5
varied (shown in figure). (B) R
obtained in the absence of isomerization
QueF and 7.8 µM preQ0). (F) 
(40 µM QueF and 400 µM preQ
concentrations (40 µM QueF and 400 µM preQ
A. 
C. 
E. 
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thioimide formation in QueF under transient state 
(final concentrations in reaction: 62 µM QueF, 50 mM 
), 50 mM KCl, 250 µM MnCl2, 1 mM DTT and preQ
esiduals for the fit in the presence of an isomerization step
. (D) Thioimide formation at low preQ0 concentrations 
Single exponential fit for thioimide formation at high preQ
0). (F) Double exponential fit for thioimide formation at high preQ
0). 
B. 
D. 
F. 
    
 
 
0 concentration was 
. (C) Residuals 
(40 µM 
0 concentrations 
0 
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Figure 45: Transient state analysis of NADPH binding to E78A 
(A) Single exponential decay fit for NADPH binding (100 µM E78A-*PreQ0 and 69.28 µM NADPH). (B) 
Double exponential decay fit for NADPH binding (100 µM E78A-*PreQ0 and 69.28 µM NADPH).  (C) 
Global analysis of NADPH binding to E78A-*PreQ0.  (C) Residuals for the global fit analysis.  The 
reaction was carried out at 20 ºC in 50 mM potassium phosphate buffer (pH 6.5), 50 mM KCl, 250 µM 
MnCl2, and 1 mM DTT.  The E78A QueF mutant (200 µM) was incubated with 700 µM preQ0 for 10 
minutes before mixing with varying concentrations of NADPH.  The final concentrations of NADPH in the 
assay were; 16, 23.5, 31.8, 39.4, 50.3, 57.44, and 69.28 µM.  The final concentration of E78A-*PreQ0 in 
the reaction mixture was 100 µM. 
 
  
B. A. 
C. D. 
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Figure 46: Transient state analysis of NADPH fluorescence  
(A) Global analysis of NADPH binding to QueF-*PreQ0.  (B) Residuals for the global fit analysis.  The 
reaction was carried out at 20 ºC, 50 mM potassium phosphate buffer (pH 6.5), 50 mM KCl, 250 µM 
MnCl2, and 1 mM DTT.  The final concentrations of NADPH in the assay were 8; 16, 23.5 µM and QueF-
*PreQ0 was 72.5 µM. 
 
  
8.0 µM 
16.0 µM 
23.5 µM 
A. 
B. 
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Figure 47: Thioimide and NADPH spectra  
 
                       
 
Figure 48: Transient state analysis of thioimide loss 390 nm.  
The reaction was carried out at 30 ºC in 50 mM potassium phosphate buffer (pH 6.5), 50 mM KCl, 250 µM 
MnCl2, and 1 mM DTT, with final concentrations of QueF-*PreQ0 at 180 µM in the presence of 20 and 
26.3 µM NADPH.  
20 µM   
26.3 µM   
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Figure 49: Thioimide decomposition. 
 
Thioimide decomposition was monitored at 370 nm at 30 ºC, in the presence of 50 mM potassium 
phosphate buffer (pH 6.5), 50 mM KCl, 250 µM MnCl2, 1 mM DTT, ~ 154, 158 and 161 µM QueF-
*PreQ0. 
 
                               
 
Figure 50: SDS/PAGE analyses of QueA purification. 
MW marker ;  lane 1 , Cell free extract; land 2  , flow through; lane 3, wash 1; lane 4 wash 2; lane 5, wash 
3 ,  lane 6, purified His6-QueA. 
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Figure 51: LC analysis of tRNAtyr hydrolysates before and after QueA catalysis  
 
 
 
Figure 52: Mass spectrometry analysis of the oQ generated from QueA reactions  
(A) Unlabelled AdoMet (B) 5’S-[5-D]-AdoMet (C) 5’ R-[5-D]-AdoMet 
 
 
m/zm/zm/z
A B C
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A. 
  B.                        
            
 
Figure 53: AdoMet NMR analysis. 
(A) AdoMet showing the stereospecificity of the C5' hydrogens (B) Proton NMR of the AdoMet used in 
the determination of stereospecific abstraction by QueA. The proR proton is at the chemical shift of δ 4.05 
in the unlabeled AdoMet while the proS proton is at the chemical shift of δ 3.919.  
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Figure 54: Possible routes for the formation of G
 
 
Figure 55:  Alignment of unimodular FolE (GTP cyclohydrolase I) and YkvM (QueF) sequences.  
The conserved Cys and Glu found in the substrate binding pocket of both protein families are indicated by 
asterisks. The QueF motif, specific for the QueF family, is highlighted in green. 
Cys residues found in FolE and not in QueF are highlighted in blue. Other catalytic residues in FolE not 
found in QueF are highlighted in yellow. The absence of the zinc
the best identifier of QueF sequences in genome databases. Taken from 
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+
. 
The zinc binding His and 
-binding and catalytic residues of FolE is 
reference (47) 
 
 
 
141 
 
                         
 
Figure 56: Three-dimensional model B. subtilis QueF.  
Putative active site of B. subtilis QueF based on the homology model built from the crystal structure of E. 
coli GTP-CH-I.  The active site is located at the interface between two monomers shown in light and dark 
grey.  Potential active-site interactions are indicated.  The conserved QueF motif region is highlighted in 
green.  The conserved Glu characteristic of T-fold enzymes and the invariant Cys shared between QueF and 
GTP-CH-I are shown in black.  
 
                   
 
Figure 57: Proposed chemical mechanism for the QueF catalyzed reaction. 
 
                  
 
Figure 58: Partial structure of QueF with bound preQ
tryptophan residue in the presence and absence of preQ
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0 showing the electrostatics around the 
0 
 
 
  
      
Figure 59: NADPH quenching in a 
 
Proposed mechanism for the observed reaction shown below (summary of the determined rates is shown in 
table 4). 
 
[mechanism]
 E-S + NADPH                
 E-S.NADPH                  
ES.NADP+                     
ES + NADPH                  
ES.NADPH                    
FS.NADPH                    
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reaction with QueF-*PreQ0 under mutiple turnover conditions
   E-S.NADPH      : kas   kds
    ES.NADP+         : k1 
       ES + NADP+    : k2 
    ES.NADPH        : k3   k-3 
      FS.NADPH        : k4   k-4 
      F.P.NADP+        : k5
 
 
 
. 
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Table 1 : Edman Degradation results. 
Bands correspond to the bands in Figure 18A. 
Band Name  N-terminal sequences 
A  HMDSPD; DSPDLG  
B  ELTSI  
C  IFKKSF, KKSFIG ( minor SIFKKS)  
D  SIFKK  
 
Table 2 : G+ formation as function of pH 
 
 
 
 
 
 
 
Table 3 : Calculated rate constants for E78A-PreQ0 binding NADPH at 20 °C 
Constant Value   
kas 0.20 µM-1s-1 
kds 0.24 s-1 
k1 1.18 s-1 
k
-1 0.12 s-1 
 
 
 
Table 4: Calculated rate constants for wild type QueF for NADPH binding and catalysis at 20 °C 
(NADPH fluorescence) 
Constant Value 
kas  0.06 µM-1s-1 
kds 0.20 s-1 
k1 0.12 s-1 
k2 0.067 s-1 
k3 0.060 µM-1s-1 
k
-3 0.20 s-1 
k4 1.2 s-1 
k
-4 0.053 s-1 
k5 0.12 s-1 
 
pH G+ 
5 Absent 
6 Absent 
7 Present 
8 Present 
8.5 Present 
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Table 5: Calculated rate constants for wild type QueF for preQ0 binding and catalysis 20 °C 
(tryptophan fluorescence) 
Constant Value 
kas  1.32 µM-1s-1 
kds  7.95 s-1 
kr (thiomide formation) 1.30 s-1 
 
 
 
 
Table 6: Calculated rate constants for C55A QueF for preQ0 binding 20 °C (tryptophan 
fluorescence) 
Constant Value 
kas  1.06 µM-1s-1 
kds  1.35 s-1 
 
 
 
 
Table 7: Other rates determined by UV absorbance determined at 30 °C 
Constant Value 
Thoimide formation (370 nm) 2.55 s-1 
Thioimide reduction (390 nm)  0.24 s-1 
Thiomide decomposition (370 nm) 4.81 x 10-6 s-1 
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